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The unique properties of CNTs lead CNTs attractive in biological engineering 
applications. It is expected to use CNT based biomaterials for clinic use in the near 
future.  CNTs can be used to tune cellular fate through bother extracellular pathway and 
intracellular pathway. CNT based biomaterials has been applied into bone, nerves, and 
cardiovascular system. There has also been progress in the use of CNTs in controlling 
cellular alignment, to enhance tissue regeneration, growth factor delivery and gene 
delivery. 
Pluripotent stem cells (hPSCs) offer a promising tool in tissue engineering 
strategies, as their differentiated derivatives can be used to reconstruct most biological 
tissues. These approaches rely on controlling the extracellular and intracellular cues that 
tune the ultimate fate of hPSCs. In this context, significant effort has gone to parse out 
the role of conflicting matrix-elicited signals (eg. topography and elasticity) in regulation 
of macroscopic characteristics of cells (eg. shape and polarity). A critical hurdle lies in 
our inability to recapitulate the nanoscale spatiotemporal pattern of these signals. We 
used CNTs as a tool to tune nanoscaled architecture in cellular microenvironment in 
Chapter 2 and Chapter 3. After recapitulating the basic understanding of how CNT 
pattern controlling cellular polarization and human embryonic stem cell attachment in 2D 
substrate in Chapter 2, we took a step forward by developing a porous scaffold with 
appropriate mechanical strength and controllable surface roughness for bone repair in 
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chapter 3. We found that the incorporation of CNTs led to an enhanced surface roughness 
and mechanical strength of CNT-PLGA composites, which led significantly higher rate 
of osteogenic differentiation of osteoblasts on CNT/PLGA scaffolds compared to the 
control PLGA scaffold. All these basic understanding lead us to enhance the utility and 
efficacy of using CNTs for directing stem cell fate by both 2D and 3D substrate. 
On the other hand, cancer has arisen to be of the most prominent health care 
issues across the world in recent years. Doctors have used physiological intervention as 
well as chemical and radioactive therapeutics to treat cancer thus far. As an alternative to 
current methods, gene delivery systems with high efficiency, specificity, and safety that 
can reduce side effects such as necrosis of tissue are under development. Although viral 
vectors are highly efficient, concerns have arisen from the fact that viral vectors are 
sourced from lethal diseases. With all this in mind, rod shaped nano-materials such as 
CNTs have become an attractive option for drug delivery due to the enhanced 
permeability and retention effect in tumors as well as the ability to penetrate the cell 
membrane. In Chapter 4, we successfully engineered PLGA functionalized CNTs to 
reduce toxicity concerns, provide attachment sites for a pro-apoptotic protein, caspase-3 
(CP3), and tune the temporal release profile of CP3 within bone cancer cells. Our results 
showed that CP3 was able to attach to functionalized CNTs, forming CNT-PLGA-CP3 
conjugates. We show this conjugate can efficiently transduce cells at dosages as low as 
0.05 g/ml and suppress cell proliferation up to a week with no further treatments.  
Overall, our results showed CNTs were promising to tune cell fate both externally 
and internally.   
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Introduction: Carbon Nanotubes in Biomedical Engineering Applications 
 
1.1.      Carbon nanotubes 
Carbon nanotubes (CNTs) were first discovered by Iijima and Baughman [1, 2]. A 
single CNT is one or multiple layers of graphene sheets which roll up. Depending on the 
number of the graphene sheets, CNTs are mainly categorized into single wall carbon 
nanotubes (SCNTs) and multi wall carbon nanotubes (MCNTs) (Figure 1. 1) [3]. SCNTs 
(Figure 1. 1A) has a diameter close to 1 nm with a varied length from nanometer to 
centimeters. There are two models for MCNTs (Figure 1. 1B): one is Russian doll model, 
while the other is parchment model. For Russian doll model, graphene sheets are 
arranged in concentric cylinders.  For the parchment model, a single sheet of graphene is 
rolled up with several walls of grapheme sheets, like a scroll of newspaper. The interlayer 
of distance for MCNTs is approximately 0.34 nm for those two models of CNTs [3]. The 
Russian doll model are more commonly seen. In particular, double wall CNTs count for a 
special subcategory in MCNTs. It has a similar property as SCNTs, but its chemical 
resistance is more close to MCNTs [3, 4].  Besides these two major categories, there are 
also new categories existed since 1990s:  torus CNTs [5], nanobud CNTs [6], graphened 





Figure 1. 1 Illustration of SCNT and MCNT. A. SCNT which has only a layer 
of graphene. B. Russian doll model MCNT, several layer of tubes were 
concentric arranged to form a MCNT. 
  
Both CNT categories exhibit extraordinary chemical and physical properties. 
CNTs hold unique physical and chemical properties: such as high surface to volume ratio, 
high modulus, super electrical and thermal conductivity, super hydrophobic and inertia 
[8]. Owing to CNTs’ extraordinary thermoconductivity, electroconductivity and 
mechanical property, CNTs find their applications as additives in structural materials 
such as golf stub, boat, aircraft, bicycles etc. Other than that, CNTs are extremely 
attractive in composite materials [9, 10], electrical device [11-14], hydrogen storage [15, 
16], biomedical engineering [17-22], etc.. We are extremely interested in using CNTs in 
biomedical engineering applications. 
 
1.1.1. Size 
CNTs are nanosize materials. CNTs usually have a diameter smaller than 50 nm 
depends on the numbers of the graphene layers [23].  The length of CNTs are varied 
depending on the fabrication techniques and ranging from nanometers to even 
centimeters [24]. However, the diameters of CNTs are more stable at the range of several 
to several tens of nanometers, constructing as high aspect ratio as 132,000,000:1, 
Therefore, CNTs shape like a needle, facilitating the cellular penetration. Meanwhile, 
CNTs also maintain high ratio of surface area to volume, resulting a higher loading 
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capacity. Relying on those properties, CNTs could be very efficient in trafficking 
biological cargoes in biomedical engineering application. 
  
1.1.2. Mechanical Strength 
CNTs are one of the strongest and stiffest materials in the world in terms of 
tensile modulus and elastic modulus. Graphite, which has a similar structure as 
graphene, had an in-plane modulus of 1.06 TPa. Considering CNTs are layers of 
graphene, CNT should display a similar stiffness [25]. Therefore, a couple of groups 
focused on attenuating mechanical property of CNTs. Since 1990s, a number of groups 
have conducted tests to discover the mechanical strength of CNTs. They found that the 
modulus were ranging from tens to hundreds of GPa. With technique developed, it has 
been demonstrated the Yong’s modulus of a single CNT was approximately 1 TPa [26-
29], which was 5 times than stainless steel. Note that CNTs are extremely light that its 
density is approximately 1.4 g×cm-1, CNTs’ specific strength can reach 4.8×104 
KN×m×Kg-1, which is 3000 times than high carbon steel. CNTs also had a high elastic 
modulus ~50GPa, with a ~15 % elongation at break. However, CNTs bundles were not 
as strong as individual CNTs. The weak shear interactions between CNTs and CNT 
layers led the mechanical strength at GPa level. CNTs’ hollow structure and high aspect 
ratio also led CNTs to undergo buckling rather than elastic deformation. What’s 
interesting was that CNT bundle would only withstand a pressure lower than 25 GPa 
[30]. All those data were usually obtained in axial direction of CNTs. The strength of 
CNTs in radial directions were believed to be softer than its axial direction, which was 
confirmed by AFM in the range of several GPa [31, 32]. Take a step forward, how do 
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CNTs maintain such a strong property? The answer is because their unique molecular 
structure. The carbon atoms which make CNTs up are bound by covalent sp2 bond, 
which are stronger than sp3 hybridization found in alkanes and diamonds.  
Overall, CNTs can be used to strengthen the mechanical properties of composite 
materials as we mentioned above. However, particularly, CNTs were also used to 
enhance the mechanical property for bone tissue engineering by directly injection into 
and indirectly contact to bone tissue relying on CNTs’ super mechanical performance 
[33, 34]. 
 
1.1.3. Electrical property 
 
Figure 1. 2 m, n indices to describe the 
electrical nature of carbon nanotubes. 
Take the origin carbon as the number 1 
carbon, draw vector a1 to atom 3 and 
draw vector a2 to atom 5. Coming from 
A to B, the number of atoms coming in 
a1 and a2 directions are m and n. 
 
The electrical property of CNTs is based on how the graphene sheet is rolled up. 
The nature of the rolling up of CNTs is described using the indices (m, n) (Figure 1. 2). 
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In general, in a single phenol ring of CNTs, take the origin carbon as the number 1 
carbon, draw a vector a1 to atom 3 and draw another vector a2 to atom 5. Coming from 
A to B, the number of atoms coming in a1 and a2 directions are m and n. For SCNTs, if 
m=n, the nanotube is described as armchair tube, which carbon patterns like an arm 
chair. If m or n equals zero, the CNTs form a zig-zag pattern. All the other cases of the 
indices refer as chiral tubes [35]. These indices can be used to predict the electrical 
properties of CNTs.  Particularly, for the case of armchair pattern (m=n), CNTs 
exhibited metallic property with a band gap of zero eV. For the case of m-n≠3, CNTs 
were semi conductive with a band gap of approximately 0.5 eV. For the case of m-n=3, 
CNTs were semi metallic with a band gap of approximately 10 meV [35]. Based on 
these electrical properties, CNTs were able to be used as a chemical sensor, to monitor 
the environmental change, control chemical process, pre-screen diseases [36, 37]. For 
MCNTs, the electrical property was determined by each single layer of graphene sheets.  
 
1.1.4. Optical properties 
The optical properties of CNTs refer to absorption, photoluminescence and 
Raman spectrum. These optical properties allow us to characterize or detective CNTs 
quickly and nondestructively. These optical properties of CNTs derive from CNTs’ 
electronic transition within one-dimensional density of states (DOS) [38]. Note that a 
single CNT can be considered as a one dimensional material. It should hold a typical 
feature of one-dimensional crystals. That is their DOS is not a continuous function of 
energy as a 3 dimensional material has, but it descends gradually and then increases in a 
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discontinuous spike. Those sharp peaks find in one-dimensional materials are called Van 
Hove singularities.   
Due to Van Hove singularities, CNTs preserve 3 major remarkable optical 
properties: (A) Optical transitions occur between the cross over transitions v1 - c1 
and v2 - c2. However, these crossover transitions were dipole-forbidden, thus were 
extremely weak and could only possibly be observed by using cross-polarized optical 
geometry [39]. Note these crossover transitions of semiconducting or metallic CNTs are 
traditionally labeled as S11, S22, M11, etc., or, if the conductivity of CNTs is unknown or 
unimportant, as E11, E22, etc.. (B) Considering that the energies between the Van Hove 
singularities depends on CNT structure. The optoelectronic properties of CNTs can be 
tuned and controlled by varying CNT structure, Such designing ability has been 
experimentally demonstrated by using UV illumination of polymer-dispersed CNTs [40]. 
(C) CNTs had rather sharp (~10 meV) and strong optical transitions. It is relatively easy 
to selectively excite CNTs having certain (n, m) indices, therefore giving us the chance 
to detect optical signals from that specific type of CNTs. 
Optical absorption in CNTs originates from electronic transitions from crossover 
transitions. The transitions are relatively sharp and can be used to identify specific CNT 
types (m,n indices). However, it is not optimistic to distinguish different CNT types in a 
CNT mixture. This is because that the sharpness of the gap deteriorates with increasing 
energy. Many CNTs had very similar E22 or E11 energies, significant overlap of different 
types of CNTs occurred in absorption spectra [41-44]. Furthermore, CNTs were close to 
a black body (absorbance equals to 1) as well. For instance, vertically aligned SCNT 
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array could have absorbance of 0.98–0.99 from the far-ultraviolet (200 nm) to far-
infrared (200 μm) wavelengths [45]. 
Raman spectroscopy requires very small amount of sample but still has good 
spatial resolution (~0.5 micrometers) and sensitivity for SCNT. The data obtained from 
Raman spectroscopy would also examine the purity as well. Consequently, Raman 
spectroscopy is becoming the most popular technique to characterize CNTs. Moreover, 
what put Raman scattering more attractive for SCNT is the resonant property would 
provide more applications in biomedical engineering [46, 47].  
 
1.1.5. Thermal properties 
All types of CNTs are good thermal conductor along tube direction as well. 
Measurement has shown that SCNT had a thermal conductivity of 3500 W×m-1×K-1 at 
room temperature. This was almost 10 times of the thermal conductivity of copper (385 
W×m-1×K-1). What made SCNT’s thermal properties more attractive was that the 
thermal conductivity along the radial direction was only 1.52 W×m-1×K-1, similar as soil. 
Considering CNT were very stable up to 2800 oC in vacuum and 750 oC in air, CNTs 
could be potentially used in one direction heat transfer [48, 49]. 
 
1.1.6. Hydrophobicity 
CNTs are super hydrophobic materials as well [50]. Hydrophobicity is benefit in 
waterproof applications. However, hydrophobicity is usually the main cause of intrinsic 
toxicity of CNTs, leading cell to necrosis. Pristine CNTs would also tend to accumulated 
and agglomerated due the hydrophobic interaction in water phase [51]. Therefore, to 
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utilize CNTs in biomedical engineering applications, the functionalization of CNTs were 
usually required. 
 
1.2.      Functionalization of carbon nanotubes 
As we mentioned above, the hydrophobicity of CNTs need to be changed to 
hydrophilic in order to reduce the intrinsic toxicity of CNTs. Another reason for to do so 
is that CNTs requires functionalization to be able to disperse in biological environment. 
In general, the functionalization of CNTs can be categorized into covalent and non-
covalent [52]. Non-covalent binding relies on the interactions between CNTs and 
linkers. Covalent binding relies on chemical reactions to add reactive groups to CNTs 
which facilitate further modifications such as protein/polymer conjugation. 
 
1.2.1. Non-covalent functionalization of carbon nanotubes 
For non-covalent functionalization of CNTs, pristine CNTs remain intact and 
there is no atomic damage on either sidewall or terminal of CNTs. The dominant 
interaction between CNTs and their adducts is π-π stacking [53]. Aromatic molecules 
can be immobilized on the poly-aromatic graphitic surface of CNTs due to π-π stacking 
(Figure 1. 3 upper panel). For instance, Pyrene derivatives were used to stabilize CNTs 
from aggregation [54]. DNA and RNA were also able to immobilize CNTs due to the π-
π stacking between nucleobase and CNTs [55, 56]. Moreover, proteins could be 
functionalized on CNTs by interaction between benzene groups and CNT sidewall. 
Besides π-π stacking, van der Waals forces and hydrophobic interaction are other key 
forces for CNTs and adducts. For example, amphiphiles were used to suspend CNTs in 
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water phase [57-59]. The hydrophobic methylene chain wrap over the CNTs Figure 1. 3 
bottom panel) due to hydrophobic interaction. The hydrophobic backbone adhere to the 
body of CNTs and the hydrophilic water-soluble head enhance the ability of CNT 
conjugates to disperse in aqueous solution. Tween-20, Triton X-100 and pluronic 
triblock polymers, were used to reduce protein binding or to obtain a well suspended 
CNTs water solution. This non-covalent binding allows CNTs to be able to conjugate a 
variety of cargoes which have biological function. The newly formed biological 
conjugates can deliver these cargo into a living cell. There is another key advantage for 
non-covalent binding. That is the structure of CNTs are not broken down, which let non-
covalent bounded CNTs preserve their unique physical and chemical properties. 
However, there are also critical concerns that A) non-covalent bounded molecules are 
more easily detached from CNTs; B) biological molecules are tending to be degraded; 
and C) amphiphilic surfactants are able to lyse cells and denature proteins. 
 
Figure 1. 3. Schematic of non-covalent binding of CNTs. Upper panel on the right 
showed aromatic rings of adduct molecules adhere to the main body of CNTs due to 
π-π stacking. Bottom panel on the right showed molecular chains adhere to main 




1.2.2. Covalent functionalization of carbon nanotubes 
 
Figure 1. 4 Schematic of covalent binding of CNTs [52].  (a) CNTs are oxidized and 
then conjugated with hydrophilic polymers; (b) photoinduced addition of azide 
compounds with CNTs; (c) Bingel reaction on CNTs; (d) 1,3-dipolar cylcoaddition 





For covalent binding (Figure 1. 4), the most commonly used functionalization 
method to function CNTs is oxidation [60]. In brief, oxidation reagent such as hydrogen 
peroxide and nitric acid is used to form carboxyl groups on the terminal or side wall of 
CNTs. These oxidized CNTs are further attached to hydrophilic polymers to prevent 
aggregation due to charge screening effects. In the community, a couple of different 
polymers such as PMMA [61], PEG [62], etc. were successfully attached to oxidized 
CNTs. This further conjugation of polymers allows attachment of biological functional 
molecules. In our group, we firstly fabricated CNT-PLGA conjugate for the use of gene 
delivery in biological system (Chapter 4).  
Second route of covalent functionalization of CNTs is cycloaddition. This type 
of reactions happens on the sidewall of CNTs. One of the unsaturated bond in aromatic 
ring of CNTs is broken and a new cyclic adduct will be added on. There are three major 
cycloaddition reactions in functionalization of CNTs. Azides were introduced onto 
sidewall of CNTs by photochemistry [63]. Carbene compounds were generated on the 
sidewall of CNTs by Bingel reaction [64]. 1, 3-dipolar cycloaddition have also been 
used to generate functional groups to the sidewalls of CNTs [65]. 
These covalent reactions impair the atomic arrangement of carbon and 
reorganize electron cloud of CNTs. Therefore, the electron and thermal conductivity and 
optical properties are altered. Despite this disadvantage, covalent functionalization could 
have the biological cargoes linked to CNTs to be more stable in biological system. 
Functionalized CNTs were also be able to maintain temporal drug release profiles (as 




1.3.      Cell fate regulation 
Tissue formation, function, regeneration after damage and pathology formation 
are the result of temporal and spatial organization of individual cell fates [66]. Individual 
cell fate is the consequence of the cross talk of cells to its microenvironment and 
neighboring cells. In brief, cells sense the physical cues and soluble chemical cues by 
the receptors on the cell membrane [67]. These signaling cues are read and translated 
into intracellular cues. Then, cells are able to differentiate to the desired lineage. Thus, 
we have two options to direct cellular behavior: (i) construct biomimic 
microenvironment which favors desired cellular differentiation; and (ii) deliver key 
intracellular cues into cell and control the cell fate. 
 
1.3.1. Extracellular cues to regulate cellular behavior 
  
Figure 1. 5 Schematic of Extracellular matrix regulating cell fate. Cells will sense 
physical signals and soluble signals and express genes. The receptors translate 
signaling cues through PLC RAS and PI3K to gene expression. The extracellular cues 
includes physcial signals, soluble signals and cell-cell interactions. Physical signals 
includes fribronectin, fibrillin, vitronectin, collagen, laminin and other stromal 
properties. Soluble factors includes growth factors cytokins and outsourced chemical. 




Extracellular environment is the area full of surrounding cells and signaling 
molecules [66]. There are three major types of effectors: (1) insoluble signaling 
molecules, such as extracellular matrix proteins (ECM): collagen, fibronectin, 
vitronectin, elastin, etc.; (2) soluble signaling molecules such as growth factors and 
cytokines; and (3) cellular membrane proteins involved in cell-cell contact (Figure 1. 5).  
In terms of engineering regenerative tissue by controlling extracellular matrix, 
scaffold architecture, fibrils organization, mechanical strength, in combination of surface 
topography are key effectors to modulate cell fate [66]. For instance, cellular behavior 
was found to be influenced by microenviromental stiffness [66]. Cells were less 
migrated due to reduced spreading and disassembling of actin while they are seeding on 
a weak gel, cells behaved the opposite on stronger scaffold in contrast [68]. Moreover, 
scaffold should be able to withstand cell contractile forces which generated by via cell 
and scaffold [69, 70]. On the other hand, cells preferred to proliferate, migrate and 
mature on substrate which has similar modulus as their donors. Bone exhibits strong 
mechanical properties since it provides structure stability for the body and it allows for 
millions of loading cycles throughout a person’s lifetime [71]. However, both natural 
and synthetic polymers were low in strength which couldn’t meet the requirement for 
bone tissue engineering that bone cement must meet approximate mechanical strength of 
where it is replacing, eg. human trebecullar bone’s compressive modulus is 5 to 50 MPa. 
Either crosslinking or blending with high stiffness materials should be carried out to 
enhance the mechanical strength of polymer substrate for bone tissue engineering. As a 
result, high modulus materials are preferred for bone tissue engineering. 
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Surface roughness or surface topography is another important property that 
allows for osseointegration in scaffolds, as demonstrated by Goldberg group, Feighan 
group and D’Lima group [72-74]. Topography would affect cell spreading and cell 
activities [75], could significantly increase total surface area as well that cells would 
sense and migrate [76]. Additionally, Cells could sense surface grooves which would be 
either wide or narrow and in turn cytoskeleton would adjust to it [77]; cells also could 
respond to microscale changes of the surface by tuning cell orientation and motility [78]. 
These micro or nano scale differences could be achieved by fabrication process such as 
introducing nano materials into basal materials and using mirco/nano fabrication 
techniques. In Chapter 3, creating a scaffold with certain surface roughness is the first 
challenge. Then, cells would sense these factors by membrane receptors [67]. These 
factors would be transduced into intracellular signals, affecting gene expression through 
receptor mediated transduction pathways, such as integrin pathway, mitogen activated 
protein kinase pathway, mechano-transduction pathway, etc.. Therefore, to engineer 
microenvironment with proper property could lead cells to a desired fate. 
 
1.3.2. Intracellular cues to regulate cellular behavior 
Other than physical cues; genes, transcription factor, and signaling molecules can 
induce cell differentiation and control cell phenotype as well (Figure 1. 6). 
Subsequently, approved clinical gene therapy was started in 1990s [79]. More and more 
gene therapies either in experimental or clinical stages have been proved promising in 
curing human diseases. However, there is still a challenge that a safe, efficient and long-




Figure 1. 6 Schematic of how intracellular cues to regulate cell fate. Genetic materials 
and transcriptional factors are delivered into cell and regulate gene expression. In 
brief, DNA or RNA conjugates to gene factors firstly, and then the whole conjugate 
will bind to membrane receptor. Through endocytosis the whole conjugate will be 
absorbed by cell. Thus, DNA or RNA will be released and finally affect gene 
expression.  
 
Currently, retrovirus [81], adenovirus [82] and adeno-associate [83] viral vectors 
are major types gene vectors widely used due to their ability to infect cells and transfer 
target genes. The ideal gene vectors need to fit such requirements that (i) can transduce 
genes into specific target cells without infecting normal cells; (ii) can integrated into the 
target genome with high efficiency, and (iii) the transcriptional unit should be responded 
to the regulatory elements. Through viral vectors (Figure 1. 7) are beneficial in efficient 
delivery and transducing cells, there are still concerns which emphasized on that some of 
viruses are deadly diseases intriguer, such as human immunodeficiency virus (HIV) and 
human T-cell lymphotropic virus (HTLV) (Figure 1. 7). Additionally, some virus may 




Figure 1. 7 Schematic of vectors used in gene therapy and drug delivery. There are 
two major categories: viral vectors and non-viral vectors. Commonly types of viral 
vectors are: adeno virus and retro virus, which differs from the genetic materials 
incorporated inside (RNA and DNA respectively). Commonly types of non-viral 
vectors are liposomes, polymers and dendrimers, which are usually positively 
charges in order to facilitate DNT/RNA conjugation.  
 
Consequently, non-viral vectors (Figure 1. 7) are taken into considerations. 
Polymers and lipids are most commonly explored materials for drug delivery. Synthetic 
polymers such as PEG [84], PLA [85] and PLGA [86]; natural polymers such as 
chitosan [87], collagen [88] or gelatin [89] and lipids [90] were used to synthesize 
nanoparticles, liposomes and micells. These polymers and lipids can be either 
chemically modified or not modified to encapsulated drugs. Liposomes are spheres 
contain a separate liquid phase from the element which could protect the genes from 
degradation. Drugs are released in a controlled manner due to surface and bulk 
degradation or phase transition. However, concerns arise that immune response may 
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occur due to heterogeneity of ex-original materials and efficiency is low. Hence, there is 
a need to construct a high efficient non-viral vector. 
 
1.4.      Carbon nanotubes in biomedical engineering applications 
The unique properties of CNTs lead CNTs more attractive in biological 
engineering applications. It is expected to use CNT based biomaterials for clinic use in 
the near future.  CNTs can be used to design mechanical enhanced scaffold to stimulate 
cellular growth. CNT based biomaterials has also been applied into bone, nerves, and 
cardiovascular system. There has been progress in the use of CNTs in controlling 
cellular alignment, to enhance tissue regeneration, growth factor delivery and gene 
delivery. 
 
1.4.1. Carbon nanotubes to controlling cell alignment 
As we indicated above, area of cell expansion and topography play important 
role in cell survival, differentiation, vascularization and cancer development. A few 
studies have already demonstrated that mesenchymal stem cells (MSCs) can be 
differentiated into multiple cell line by simply controlling the disorder or the dimension 
of nanostructures [91]. The result showed the differentiation found not many differences 
in the case where soluble cues were used. Cell polarization induced by alignment could 
be an answer to the critical hurdle of tissue engineering: lack of enough vascularization 
in the scaffolding materials (200 μm deeper in the scaffolding materials). More 
interestingly, take tumorigenic fibroblast as an example, they lay down collagen in an 
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aligned fashion, facilitating cell migration and tumor generation. Normal fibroblast only 
lay down collagen in a random fashion, forming normal phenotype.  
CNTs are nanosized rod-like materials. Despite their fascinating electrical and 
thermal conductivity, they can be used to engineering nano topography on 2D substrate 
in an aligned manner. Currently, there were several methods have been developed to 
align CNTs. Microfluidic flow [92], DC electricity [93], centrifugal forces [94], and 
micro patterning [95] were all used to align CNTs on 2D substrate. A variety of cell 
lines such as MSCs [96], Chinese hamster ovary cells [97], etc. was successfully aligned 
on this 2D substrate. The successful alignment of CNTs on 2D substrate would also 
increase the future application of electrical shock and growth factor conjugation for 
further induction of either differentiation of stem cells or the maturation of adult cells. 
We may also utilize this CNT to study cell polarization and tumor genesis. In our group, 
we were trying to develop a CNT based 2D substrate for cellular attachment and 
alignment for both adult cells and single human embryonic stem cells (hESCs) (Chapter 
2). The further application would have been utilize this substrate for inducing hESC 
differentiation at single cell level. 
 
1.4.2. Carbon nanotubes for bone tissue engineering 
CNTs have been used to study neurogenesis [98], cancer treatment [99] and 
especially in osteogensis [100].  There have been several reports of the influence of 
CNTs on osteoblastic cells in vitro, most of these studies indicated that CNT promote 
the proliferation and cell growth of osteoblastic cells [34, 101, 102]. This is a valuable 
characteristic of CNTs for its application in bone tissue regeneration. Furthermore, 
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investigators have shown that CNTs possess compatibility with bone tissues that CNTs 
neither increased the inflammation of the bone tissue, nor blockd the bone tissue 
regeneration. In contrast, CNTs provided assistance in bone tissue regeneration and 
showed integration with the tissue [103]. More interestingly, they could integrate 
successfully into bone tissue [8]. 
Zanello et al. discovered that osteoblasts change morphology and express plate 
shape crystals in the presence of CNTs [34]. These osteoblasts which exposed to CNTs 
were more differentiated and osteocyte-like as compared to osteoblasts cultured on a 
glass surface which exhibit a flat morphology [104]. Plate shaped crystals aggregated in 
clusters outside the cells and were similar in shape to hylauic acid found in woven bone 
[105]. In another route, Yi et al. found gold nanoparticle coated surface promote 
osteogenic differentiation through mitogen-activated protein kinase p38 MAPK 
pathway. Osteoblasts sensed gold nanoparticles via integrin receptors and induced p38 
kinase activation which upregulated osteogenic differentiation gene expressions [106]. 
Kim et al. also demonstrated Ti surface roughness enhances osteoblast differentiation 
via mediating MAPK pathway. Bone formation genes were expressed by activating 
protein kinase A (PKA) due to occupation of integrin receptors [107]. Moreover, studies 
have shown genes code BMP-2, osteonectin and osteopotin have been upregulated under 
exposure of CNTs [108-110].  
As a result, more CNT composites are taken into account for bone tissue 
engineering. Abarretegi et al. developed a chitosan/CNT scaffold and evaluate its effect 
in tissue engineering. Scaffold performed a satisfactory result of cell adhesion, cell 
viability, and cell proliferation on the external surface [111]. Meanwhile, with the 
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addition of rhBMP-2, cells were differentiated towards osteogenic lineage. Furthermore, 
Mikos et al. fabricated an ultra-short single wall CNT nano composite and evaluated the 
effects of mechanical strength, porosity and material composition on bone marrow stem 
cells. Results showed CNT materials hold promising potential in bone tissue engineering 
with tunable porosity and mechanical strength [112]. Edward et al. developed a 
PLGA/CNT electronic spinning nanofibers, not only are cell growth supported, but also 
full range of electronic conductivity and mechanical property of CNT are fully utilized 
[113]. It has been suggested that CNT is a good type of material for bone regeneration. 
Thus, a promising chapter in the study of biological applications of s in bone tissue 
engineering has begun (Chapter 3). 
 
1.4.3. Carbon nanotubes for neurogenesis 
Another more sophisticated application for using CNTs in tissue engineering is 
Neurogenesis [114]. The great electrical conductivity would provide superb environment 
for neural progenitor cells to develop axons [115]. Quite a few studies have been 
developed to study neurogenesis on CNT based substrate using different cell lines. As 
early as in 2000, Mattson et al. provided the fundamental study of neuronal 
differentiation of rat embryonic stem cell on pristine CNTs [116]. A few years later, Hu 
et al. reported they successfully tested the signal transfer between the synapse of neuron 
cells cultured on CNTs based substrate [117, 118]. Other than the neuron cell maturation, 
CNTs could also induce differentiation of hESCs to neuron lineage on a 2D substrate 
composed of CNTs [119]. It has been demonstrated that CNTs were biocompatible to 
neuron cells. Now researchers are more focused on using CNTs to assemble aligned 
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networks for neuron network regeneration, which could be potentially a big leap in 
neuron regeneration. Overall, there is one extra credit of using CNTs than using micro 
patterning: CNTs will not only provide axon growth direction, but also facilitate 
electrical signal to transfer along CNTs alignment. These properties in turn help neuron 
regeneration.  
 
1.4.4. Carbon nanotubes for drug delivery 
CNTs are needle like and very easy to penetrate the cell membrane due to its 
high volume to radius ratio. However, CNTs are not suitable for directly transferring 
genes in biological system. Subsequently, scientists discovered that functionalized CNTs 
have decreased their intrinsic toxicity [120]. The major modifications of CNT are 
covalent and non-covalent functionalization [52] as we discussed above. For a quick 
reminder, oxidation and cylcoaddition reaction are common methods in covalent 
functionalization to add functional group to CNTs’ sidewall or ends [121, 122]. For non-
covalent functionalization, CNTs are coating with a layer of molecules by π-π stacking 
or the small interactions between the molecules.  
On the other hand, as a matter of fact, drug carriers in nano sizes have 
advantages in drug delivery systems: (i) protection of delicate drugs, (ii) enhance 
absorption in selective tissues, (iii) control drug distribution profile and  (iv) enhance 
intracellular penetration [123]. But the CNT cellular uptake mechanism may differ 
depending on the functionalization and size of the CNTs [124]. CNTs have been used to 
efficiently shuttle various biological cargoes, ranging from small drug molecules [125] 
to biomacromolecules, such as proteins [126, 127] and DNA [128, 129] and RNA [130], 
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into different types of cells via endocytosis [131]. Moreover, small amount of CNTs was 
found to be biocompatible to cells.  
Carbon based biomaterials is leading a new trend in various medical areas 
especially in tissue engineering. Functionalized CNTs based biomaterials which 
enhanced its biocompatibility can continuous contact with biological systems and can be 
used as scaffold to support the cells and to deliver drugs. Liu Z. et al have successfully 
delivered siRNA by phospholipid PEG (PL-PEG) functionalized CNTs into tumor cells 
and tissue to inhibit cell proliferation and tumor ingrowth and enhance CXCR4 
expressions ex and in vivo [132-134]. siRNA was released by cut off S-S bond attached 
to PL-PEG which would not last for a longer period. Therefore, CNT are found to be an 
effective gene deliver vesicle but a long term release profile using CNT is still needs to 
be investigated. 
 
1.4.5. Carbon nanotubes for disease imaging and detection 
Because CNTs hold intrinsic optical properties, CNTs are good candidate for 
optical imaging. SCNTs have small band gaps on the order of 1 eV, makes it auto 
fluoresce in the near infrared range. The excitation and emission bands of SCNTs are 
separated broadly. The background fluorescence can be reduced. Relying on this 
properties, a few groups have developed imaging SCNTs within the cell body. Pilot 
study using SCNTs for biomedical imaging in vivo was first conducted by Weisman 
group. They successfully imaged food bio-distribution in larvae. SCNTs were also 
promising in cancer imaging that tumor retains naosized materials by EPR effect. 
Researchers reported that functionalized SCNT signals was observed in living mice 
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model. The in situ and in vivo imaging utilizes the photoluminescence property of SCNT. 
SCNT has an auto fluorescence in the near IR range, allowing real time, in vivo and in 
situ imaging in a living organism. Despite that, CNTs could be also used for cancer 
imaging by adding receptor target adducts or CNTs itself would be retain in tumor tissue 
due to EPR effect [135-140].  
 
1.5.      Toxicity of carbon nanotubes in biomedical engineering application  
The toxicity of CNTs has been drawing attention of researchers in biomedical 
nanotechnology. As of 2007, preliminary results highlighted the difficulties in 
evaluating the toxicity of this heterogeneous material. CNTs have so many parameters 
which have considerable impact on the toxicity of CNTs. These parameters includes: 
structure, size distribution surface area and chemistry, surface charge, agglomeration 
and purity. Interestingly, available data clearly showed that, CNTs could cross 
membrane barriers by its own property. Then here comes out a paradox. If raw materials 
reach the organs, they can induce harmful effects such as inflammatory and fibrotic 
reactions. Thus, functionalization of CNTs are preferred. Overall, CNTs are very 
promising in cancer therapy and controlling cell fate internally [141, 142].  
More specifically, except the use of CNTs in cancer therapy, toxicity concerns 
are always there for either stem cell differentiation or adult cell maturation. In early 
years, a number of studies have demonstrated that CNTs could have potential toxicity in 
biomedical engineering applications. Others claimed there was no toxicity at all. These 
findings are complicated and paradox. Recently, many comprehensive studies revealed 
convincing data about CNT toxicity.  CNTs retain intrinsic toxicity due to that their 
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inherent properties: super hydrophobicity and high surface area. For example, Ding et al. 
discovered that CNT increases apoptosis of human skin fibroblast [143]. In addition, the 
HEK 293 cell proliferation was found to be inhibited by co-culture with CNTs. Note, 
CNTs used in these studies were not functionalized. Liu et al. tested the cytotoxicity of 
oxidized CNTs; they found that differentiation and proliferation of MSCs were inhibited 
by oxides CNTs [144]. Not only MSCs, lymphocytes were also has been induced 
apoptosis after exposure of CNTs [145]. Since simple oxidization didn’t show promising 
in cytotoxicity, researchers then moved to decrease the toxicity by decreasing the 
intrinsic hydrophobicity of CNTs. PEGylated CNTs showed minimum toxicity in vitro 
studies. Several other reports has demonstrated the polymer functionalized CNT are not 
toxic to a variety of cell lines at all.  
CNTs are not going to be used only for in vitro studies.  To address more clearly 
for the side effect of CNTs in human body, researchers use animal models as references. 
There were a few studies discovered pristine CNTs definitely do damages to pulmonary 
system, suggesting aerosol exposure of CNTs needs to be avoided. Some further study 
demonstrated that the toxicity of the CNTs could have been size dependent. The toxicity 
of CNTs with smaller size in nanometer scale was significantly different from the CNTs 
with larger size in micrometer scale [146]. Then, more research focused on 
functionalized CNTs were accumulated in spleen and liver. However, little toxicity has 
been observed by using functionalized CNTs. Because of the successful minimization of 
toxicity by functionalization, the bio-distribution of functionalized CNTs was studied. 
Interestingly, the functionalized CNTs were able to be cleared by urea within hours. No 
 
25 
uptake or accumulation was found in organs such as liver and spleen by radioactive 
labeling. 
 
1.6.      Summary 
CNTs for biomedical engineering has been an emerging area due to the special 
and fascinating physical and chemical properties CNTs hold. Although a few conclusion 
drew from some groups may be paradox, CNTs are promising candidate in tissue 
engineering, biomedical imaging and gene delivery. However, more research attention 
should be focused on basic chemistry of CNTs functionalization and basic biology of 
degradation, distribution and clearance of CNTs in human body. In the following three 
chapters, we demonstrated the ability of CNTs as extracellular and intracellular 
regulators to control cellular behaviors.  
As extracellular matrix, we developed an aligned CNT substrate to align 
HUVEC and culture hESCs at single cell level (Chapter2). It is well acknowledged that 
culturing single hESCs is extremely difficult. By either mechanical or enzymatic 
breakdown of hESC colony, it is able to culture single hESCs. However, these single 
cells still tend to migrate to crowd together. With our newly developed CNT substrate, 
we could culture hESCs at single cell level, and could control their migrating as well. 
This is the great novelty in the Chapter 2. By culturing single hESC, we could take a 
step forward to differentiate single hESCs to desired phenotype with limited 
heterogeneity.  
We also developed a CNT containing PLGA scaffolds for bone regeneration in 
Chapter 3. Previous study has showed that CNT addition increased either stiffness or 
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surface roughness, which in turn increased osterogeneis. The great novelty in Chapter 3 
lies in that by developing a 3D CNT content scaffolds, we were able to coupling the 
surface roughness and mechanical strength to osteogenesis. As we confirmed, the 
increase of nano roughness and mechanical strength together helped improve 
osteogensis. 
As intracellular cue vesicles, a number of biological cargo has been already 
delivered intracellularly by a several types of linkers such as PEG or not. We developed 
a new CNT-PLGA conjugate to delivery biological cargoes into cells in Chapter 4. The 
innovative aspect of our DDS system based on CNT-PLGA is that we can tune temporal 





Alignment of Carbon Nanotubes: An Approach to Modulate Cell Orientation and 
Asymmetry 
2.1.      Introduction 
Stem cells are promising in tissue engineering, as their differentiated derivatives 
can be used to reconstruct most biological tissues. These approaches heavily rely on 
biophysical cues that tune the ultimate fate of stem cell and provide by cellular 
microenvironment [147]. Particularly, topography plays a crucial role in affecting cell 
behavior such as spreading, migration, and differentiation among other characteristics 
[148-150]. Focal adhesion is a key component by which cells are able to adhere to 
substrates. As cells bind to extracellular matrix (ECM) ligands, integrins are clustered 
and therefore form focal adhesion. Cells sense topographical structure through focal 
adhesion, therefore control cellular alignment and other cell behaviors [149]. Cellular 
alignment is crucial for the function of certain tissues in the human body. For instance, 
the mechanical strength of bone depends heavily on the cytoskeletal alignment of 
osteoblasts [151]. This allows us for engineering a unique topographical substrate, which 
enables integrin to attach in a controlled manner therefore affect the cell behavior and 
ultimately tissue function.  
However, the mechanism for the change of cell behavior induced by cell 
alignment remains somewhat elusive. Mechanotransduction signaling pathways are 
generally hypothesized with tension forces being transmitted from focal adhesions 
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through the cytoskeleton and ultimately to the cell nucleus [152, 153]. These forces are 
mediated by trans-membrane adhesion proteins and can therefore affect the expression of 
signaling proteins [154-156]. For instance, collagen type I is a ligand for integrins that are 
bound to integrin linked kinase. Integrin linked kinase activation has been reported to 
increase cytoplasmic levels of β-catenin, which positively affects the Wnt-β catenin 
signaling pathway. This signaling cascade can potentially result in the neurogenic 
differentiation of embryonic stem cells [154-157]. Additionally, nuclear shape changes 
via connections between the cytoskeleton and the nuclear matrix [158]. 
Nano and micro engineered topographies are of current interest to develop 
cellular alignment [159]. Stem cells were differentiated into a neuronal lineage with 
significant neurite extensions confined in the nanogrooves [159]  or along with direction 
of electronic spun fibers [160]. The differentiation of exoderm or endoderm can be 
determined via controlling the colony size of embryonic stem cells by micropatterning 
technology [161]. These studies mostly focus on a view of how cellullar alignment is 
affected by the microscale substrate. Few reports have focused on the alignment of cells 
induced by nanoparticles. Thus, we are interested in using CNTs to engineer nano 
topographies. 
CNTs have become an attractive option to biological applications for their unique 
characteristics [162, 163]. CNTs have been used as a developing platform to enhance 
nano roughness [19] among other applications [164-166]. Specifically, it has been 
confirmed statistically that CNTs were able to increase the number of focal adhesions and 
expression of vinculins [167]. Rigid dash like and dot like focal adhesion structures have 
also been monitored on CNT substrates [168]. Our previous study also demonstrated 
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increased number of cell attachment by addition of CNTs [169]. Recently, Namgung et 
al. successfully aligned human mesenchymal stem cell on CNT coated surface using a 
spin coating procedure [96]. These findings inspire us to tune cellular alignment through 
focal adhesion sites by regulating CNT substrates. 
With these in mind, our goal is to develop a platform coating aligned ligand 
functionalized CNTs to provide attachment sites, which cells can decipher and bind to. 
Our hypothesis underlies that cells will be able to recognize and adhere only to those 
CNT patterns, such that cytoskeleton will organize to adopt the aligned fashion through 
focal adhesions.  
To achieve the goal, we functionalized carboxyl CNTs with the ligand proteins 
and aligned these CNT-ligand conjugates on an Au coated glass substrate by spin coating. 
We characterize the CNT-ligand and the surface properties of substrate by various 
techniques. In addition, we used human embryonic stem cells (hESC) and human 
umbilical vein endothelial cells (HUVEC) as model cells in order to demonstrate the 
spreading and cytoskeleton organization on the substrate. The uniqueness of this paper 
lies in the ability of these patterns to control cell attachment and shape through the 
tenability of density and dispersion of these CNT-ligand conjugates. 
By developing this aligned CNT pattern, we were able to tune single hESC 
attachment and alignment of HUVEC. We have provided a new approach to tune hESC 
culture at single cell level. This would allow us for better understanding differentiation of 
hESC at single cell level. Most importantly, the differentiation of hESCs could be 
conducted at single cell level by using this CNT pattern. Potentially heterogeneity could 
avoid in hESC differentiation.   
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2.2.      Materials and methods 
2.2.1. Substrate preparation 
Coverslips were rinsed in sterilized water for 5 min, dried with lab provide air 
blow for 5 min, and cleaned with an ozone cleaner (BioForce Nanoscience) for 3 min.  
Coverslips were then coated with a first layer of 5 nm Ti and second layer of 10 nm Au 
through sputter coating (Denton Desk II Turbo Sputter Coater and Denton Desk II 
Sputter Coater respectively). For Ti coating, a vacuum at 10 Torr has been applied to the 
chamber with Ar gas blowing into the chamber. 15 seconds of sputter coating time was 
applied. For Au coating, a vacuum at 100 Torr has been applied with Ar air blowing into 
the vacuum chamber. 30 seconds of sputter coating time was applied. All Au coated 
samples were stored in petri dish sealed with parafilm till use to prevent dust. 
  Total of 100 µg of carboxyl CNTs (Nano Lab, purity>95%) were dispersed in 0.5 
ml of 0.2 mol/ml  2-(N-Morpholino)ethanesulfonic acid (pH 5.6) (MES, Acros) buffer 
under sonication for 1 hour at room temperature. 0.25 ml of 0.8 mol/ml 1-(3-
Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC, Acros) and 0.25 ml of 
0.4 mol/ml N-Hydroxysuccinimide (NHS) (Acros) in MES solution were added to 
activate carboxyl groups [170, 171]. The mixture was washed with PBS and centrifuged 
in a MW 100 KDa cutoff centrifugal filter (Millipore) (4 ml) to remove EDC and NHS at 
5000 g three times for 30 minutes each. Refill 4ml of PBS in centrifugal filter tube each 
time. Then, 5 µg of a model protein was added at 4 oC and incubated overnight. Finally, 
the mixture was washed and centrifuged in a filter to remove un-conjugated protein at 
5000 g six times for 30 minutes each [171]. Refill 4 ml of PBS and sonicated for 10 mins 
to resuspend mixture before each following centrifuge. The final CNT-protein in PBS 
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solution (resuspend in 1 ml PBS) was collected and stored at -20 oC until use. These 
studies used Matrigel (Invitrogen), bovine serum albumin (BSA) (Sigma) and fluorescent 
BSA (fBSA) (Sigma) as model proteins for characterization of adhesion to CNTs. 
Fibronectin (Sigma) and Matrigel were used to provide cell attachment for human 
umbilical vein endothelial cells (HUVECs) and human embryonic stem cells (hESCs), 
respectively. The prepared CNT-ligand conjugations were stored in -20 oC until use. 
In order to obtain the aligned CNT pattern on the surface, substrates were rinsed 
in CNT-ligand solution for 12 hours. Then CNT-ligand conjugates were aligned on the 
Au coated substrate through spin coating (Chemat Technology). The solution was spun at 
800 rpm for 10 seconds and 5000 rpm for 1 minute.  After incubation in ambient 
conditions in a petri dish sealed with parafilm for 30 minutes, aligned CNT substrates 
were gently washed with PBS and ethanol twice to remove any unseated CNT-ligand and 
remaining particles. Poly(ethylene) glycol (PEG) thiol (Sigma) is placed in ethanol 
solution (1 µl/ml) and coated onto the CNT-ligand substrate for 10 minutes to passivize 
rest of Au coated area and prevent non-specific cell attachment.  
 
2.2.2. Substrate characterization 
For transmission electron microscope (TEM) characterization, several droplets of 
homogenized carboxyl CNTs and Geltrex conjugated CNTs solution were coated onto 
200 mesh copper grids and dried at room temperature for 10 minutes. TEM images of 




For scanning electron microscope (SEM) characterization, prepared substrates 
with carboxyl CNTs were imaged with a Zeiss Ultra Plus SEM system. We use carboxyl 
CNTs instead of CNT-ligand conjugates due to the consideration of conductivity.  
Immunofluorescent images were captured with fBSA conjugated CNTs on 
substrates and imaged by a Nikon Eclipse 80i microscope.  
UV-Vis Spectrum characterization was done with 5 g/mL BSA solution and 5 
g/mL carboxyl CNT homogenized solution prepared by sonication (30 mins).  5 g/mL 
BSA conjugated CNT solution was prepared with 1 hour incubation of 5 g/mL BSA and 
5 g/mL carboxyl CNTs at 37oC followed by 1 hour incubation at room temperature. The 
unconjugated BSA was then removed with a 100K molecular weight cutoff centrifugal 
filter (Millipore) at 5000 g for 30 min for 6 times. The UV-vis spectrum was recorded 
using a Beckman Coulter DU 730 UV-Vis spectrometer with a step of 1 nm. 
 
2.2.3. Cell Culture 
Human umbilical vein endothelial cells (HUVECs) (Lonza) at passages 8-12 were 
used for this study. Cells were seeded on CNT aligned substrates at a density of 5,000 
cells/cm2 in Ham’s F12K medium (Invitrogen) supplemented with 2 mmol/L glutamine 
(Invitrogen), 1.5 g/L sodium bicarbonate (Sigma), 0.1 mg/mL heparin (Fisher), 0.03-0.05 
mg/mL endothelial cell growth supplement (BD Biosciences), 10% FBS (Invitrogen) and 
1% penicillin-streptomycin (Invitrogen). Medium were changed every 3 days, HUVECs 
were passaged every 7 days. 
hESC line H9 was purchased from WiCell with cell lines grown on a mouse 
embryonic fibroblast (MEF) (CF-1, Millipore) feeder layer in DMEM/F12 (Invitrogen) 
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with 20% KnockOut Serum (Invitrogen), 0.1 mM MEM Non-Essential Amino Acids 
(Invitrogen), 3.5 mM L-Glutamine final concentration (Invitrogen), 100 µm 2-
Mercaptoethanol (Sigma) and supplemented with 10 ng/ml human recombinant bFGF 
(PeproTech) as shown in WiCell protocols. Medium was changed daily and cells were 
passaged on every fifth day of culture with collagenase type IV (Invitrogen).  
MEF were grown in DMEM (Invitrogen) with 10% FBS (Invitrogen) and 
100U/100µg/ml of penicillin/streptomycin (Invitrogen). Medium were changed every 3 
days. MEF cells were passaged every 7 days. The passages 6 of MEF were used as feeder 
layer. 
hPSC monolayer culture with single cell passaging was established as described 
[172]. Briefly, hPSC were switched from feeder-dependent culture to feeder-free 
conditions with 20 gauge sterile steel tips. hPSCs were grown as colonies for 2-3 
passages on growth factor reduced Geltrex (Invitrogen) coated 6-well plates (BD 
Biosciences) in MEF conditioned medium supplemented with 10 ng/ml bFGF. Cells were 
passaged mechanically on day five.  
Conditioned medium was prepared as described, mitotically inactivated MEF 
through Mitomycin C (Sigma) treatment at 10 µg/ml for 2.5 hours were plated on 
gelatinized flasks (Sigma) at a density of 60,000cells/cm2, the following day cells were 
washed with PBS (Sigma), medium was changed to hESC medium without bFGF 
addition at 0.5ml/cm2 and collected every 24 hours for 7 days.  
Before cell culture the conditioned medium was filtered and supplemented with 
10 ng/ml bFGF. On the following passage, hPSC colonies were treated with TrypLE 
Select (Invitrogen) for 1 minute, gently dissociated to single cells and plated to new wells 
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at approximately 80-100,000 cells/cm2. Cells were grown under the same culture 
conditions and single cell passaged upon reaching confluence. After stabilization of the 
cell culture cells were routinely passaged as single cells on each fourth day with a 
seeding density of 50,000 cells/cm2.  
 
2.2.4. Immunochemistry 
HUVEC and hPSC single cells were allowed 2-4 hours for attachment to CNTs 
and fixed with formalin (Sigma) for 15 mins at room temperature, permeabilized in 0.1% 
Triton X-100 (Sigma) at 4 oC for 10 mins, and blocked in 4% goat serum solution at 
room temperature for 30 minutes. HUVECs were stained primarily for PECAM-1 at a 
1:500 dilution ratio (Cell Signaling) for 60 mins. PSC single cells were stained primarily 
for Oct4 at a 1:500 dilution (Santa Cruz Technology) or vinculin at a 1:100 dilution 
(Sigma) for 60 mins. Secondary antibodies were purchased from Invitrogen and used at a 
1:100 dilution for 60 mins. Rhodamine phalloidin at a 1:100 dilution (Invitrogen) was 
used to visualize cytoskeleton structure of HUVECs and hESCs (20 mins incubation). 
DAPI (Sigma) was used to visualize nuclei (1:40).  
 
2.3.      Results and Discussion 
2.3.1. Preparation and Characterization of Aligned CNT Substrate 
As shown in Figure 2. 1, Au coated coverslips were rinsed in a homogenized 
CNT-ligand solution. CNT-ligand conjugates would be able to stick to Au coating due to 
electrostatic interactions. Then, centrifugal force was applied by spin coating. The CNT-
ligand conjugates would adopt the centrifugal force and would be organized into an 
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aligned fashion over the substrate. The concentration of conjugates, rinse time, and spin 
coating procedure were adjusted to achieve an ideal performance of CNT-ligand 
conjugates on the surface for cell attachment. To prevent non-specific binding of cells to 
the non CNT-ligand area, the area with no CNT-ligand conjugates was passivized in 
PEG-SH solution at determined concentration. At last, cells were able to attach to CNT-
ligand particles only. 
 
 
Figure 2. 1 Schematic diagram showing experimental procedure for CNT substrate. 
In brief, carboxyl CNTs were functionalized with protein ligand and CNT-ligand 
conjugates were aligned on Au surface by spin coating. Then Au surfaces without 
CNTs were rendered non-adhesive by thiolated polyethylene glycol (PEG-SH) and 
cells were cultured on the substrates. 
 
Multiwall carboxyl CNTs were commercially purchased from Nanolab and 
characterized through TEM. As shown in Figure 2. 2A, the length of the carboxyl CNTs 
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used in this study is approximately 5 m with the diameter shown in Figure 2. 2B of 
approximately 20 nm. These specifications were larger than the single wall CNTs, 
facilitating more ligand conjugate to each single MCNT. Consequently, the density of 
conjugated protein per CNT will be higher than SCNT. This was a desired property 
which facilitates cell adhesion and migration [173, 174]. As we mentioned above in 
Chapter 1, toxicity concerns of CNTs in biomedical engineering would need 
functionalization of CNTs. Although using CNT as extracellular cues in vitro would 
significantly reduce the toxicity concerns of CNTs, there is still critical hurdle that CNTs 
need appropriate functionalization to desired application: provide cell attachment sites. 
There are two major types of functionalization including covalent and non-covalent 
reactions [52]. To achieve covalent binding, reactive groups [175, 176] are formulated to 
allow for further attachment of polymer [177], protein [178], and DNA [179]. In contrast, 
non-covalent binding is based on π-π stacking between CNTs and aromatic groups from 
the linkers [180]. Both functionalization would provide certain degree of protein 
attachment. However, there were reports suggesting non-covalent bound biological stuff 
may not remain stable in serum containing situations [181]. Thus, based on our goal to 
provide cell attachment sites on CNTs, we functionalized CNTs through covalent 





Figure 2. 2 Characterization of CNT-ligand conjugates and aligned CNT substrate. A. 
TEM of carboxyl CNTs. Carboxyl CNT is about 5 µm in length and 20 nm in diameter. 
B. TEM image of Geltrex conjugated CNTs. There were several protein particles attached 
to the CNTs’ sidewall as squared. C. Fluorescent image of CNT-fBSA conjugation on Au 
substrate. Green shows the positive signal of CNT-fBSA on substrate. D. UV-vis 
spectrum of CNT, BSA and CNT-BSA conjugates. CNT-protein conjugates and its 
dispersion confirmed on Au surfaces which allow cell attachment for HUVEC and 
hESCs. E. Low-magnification SEM image of aligned CNT substrate. F. High-
magnification SEM image of aligned CNT substrate. Cleary we’ve seen CNTs were in an 
aligned fashion.  
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We were able to show highly specific protein conjugation to CNTs for cell 
attachment as shown in Figure 2. 2B. This high magnification TEM image showed 
Geltrex protein conjugated to CNTs with protrusions from the sidewall of these CNTs to 
the space. The sizes of these protrusions were found to be approximately 2 nm, which 
correlated with the calculated size of the proteins comprised in Geltrex according to the 





3  [182]. Where MW is the molecular weight of the protein, NA is 
Avogadro constant. ρ is the density of the solution. Note, the molecular weight for 
common extracellular matrix is under 10-100 KDa range, resulted the diameter around 2 
nm. fBSA was used as another sample protein for demonstration as shown in Figure 2. 
2C through microscopy. CNT-fBSA were shown positively signals on the 2D substrate. 
We saw green fluorescence emitted from rod like CNTs, which is generated from fBSA 
excited by 488 nm laser. This confirms protein conjugation to CNTs on substrate, 
demonstrating the ability of CNT-ligand to provide cell attachment site on substrate. UV-
Vis absorption was also used to test the conjugation spectrometrically. As shown in 
Figure 2. 2D, CNT-BSA conjugates exhibited an enhanced absorption at 280 nm, which 
was the typical absorption of a protein. This type of UV absorption was similar to other 
studies of analyzing proteins [183]. With all these in mind, we confirmed the ability of a 
fibronectin or Geltrex protein could be conjugated to CNTs covalently. Therefore, the 
CNT-ligand conjugates would provide enough attachment sites for cell adhesion. 
Recent studies have also shown that aligned topographies were highly effective in 
directing cell differentiation and adopting specific cell behavior [154, 184-189]. Besides 
dip pen nanolithography [190], UV lithography [191] and electro-spin nanofibers [191, 
192], we were able to align CNT-ligand conjugates on Au coated coverslip. As observed 
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in low-magnification SEM images (Figure 2. 2E), the rod shaped tubes representing 
carboxyl CNTs were well aligned in the direction of centrifugal force. In the high 
magnification SEM image of Figure 2. 2F, carboxyl CNTs with different lengths were 
clearly shown in an aligned fashion throughout the substrate. Our results correlated well 
with previously report, which aligned single wall CNTs on a poly-l-lysine substrate by 
spin coating [193, 194]. Through the parameters listed in this paper, we have successfully 
developed a highly aligned multiwall carboxyl CNT substrate for its utility in cell culture 
systems. 
 
2.3.2. Adhesion of HUVEC and hESC single cell on Aligned CNT Substrate 
Cellular adhesion to the matrix is a key contributor to many cell functions 
including proliferation and apoptosis. Significant interest has been directed into how 
factors such as the topographical and mechanical cues presented in cell adhesion affect 
cellular behavior. These microenvironments have been shown to control cell spreading, 
migration, and differentiation among other characteristics. A combination of matrix 
factors such as topography, mechanics, and ligand density have all been implicated in the 
direction of cell behavior and fate [155, 174, 195]. However, these factors and interplay 
between factors remain poorly understood and have been identified as a crucial portion to 
cellular function. 
These microenvironment also play a crucial role in cell shape, which in turn also 
can affect cell behavior [148-150]. Stem cells are particularly interesting to observe cell 
shape because of the capability of differentiating into the many cell types in the body and 
contain significant potential for use in regenerative medicine and tissue engineering [159, 
 
40 
196, 197].  It is understood that mechanical and topographical cues from the hESC’s 
immediate environment can affect its cell shape and therefore differentiation lineage in 
addition to the more studied soluble factors [66, 147, 196]. Nano-engineered 
topographies are of current interest because they are able to avoid the use of biochemical 
factors, which are both expensive and difficult to control in terms of concentration [159]. 
Cellular alignment is crucial for the function of certain tissues in the human body, for 
instance, the mechanical strength of bone structures depends heavily on the cytoskeletal 
alignment of osteoblasts and their surrounding collagen matrix [151]. hESC 
differentiation can be induced by physically aligning the cells in a uniaxial manner. 
hESCs have also been shown capable of differentiation along osteogenic and neurogenic 
lineages when cultured on nanoengineered substrates [159, 197].   
Cellular alignment is highly important in bodily tissues, especially endothelial 
cells. The effects of shear stress and nanotopography on human umbilical vein 
endothelial cell (HUVEC) alignment have been studied extensively. HUVECs exposed to 
1.5 Pa shear stress demonstrated actin filament alignment after 16 hours of exposure28. 
Combined effects of micropatterned surfaces and fluid shear stress on the alignment of 
human endothelial cells were studied by Vartanian et al [198]. Nano-fibrous structures 
have also been considered as an alignment tool. Human corneal endothelial cells are 
another cell type that is able to align along the length of Type-I collagen fibrils mediated 
by integrins α2 and β1 [199]. CNTs are another highly sought after option for alignment 
of cells such as aligning cells for growth and differentiation [200]. 
Focal adhesions formation is a key component to which cells are able to adhere to 
flat substrates. As cells bind to ECM ligands integrins are clustered and focal adhesions 
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are able to form while the cell undergoes spreading. Ryoo et al. has statistically 
confirmed that CNTs were able to increase the number of focal adhesions per cell of 
NIH3T3 cells as well as the expression of vinculin [167]. Zhang et al. also observed dash 
like and dot like focal adhesion structures on CNT substrates [168].  Cells sense micro-
environmental signals through focal adhesion, controlling cell shape and function by 
integrating physical cues [149]. These findings inspire us to tune focal adhesion sites by 
regulating CNTs patterns.  With these principles and properties of CNTs in mind, this 
work establishes a platform which contains aligned CNTs to provide attachment sites to 
which cells can decipher and bind. Cells will then be able to adhere migrate in an aligned 
fashion on these CNT patterns. The uniqueness of this paper lies in the ability of these 
patterns to be used in a wide variety of cellular, particularly hESC, applications to 
promote attachment, migration, and differentiation of cells through the tunability of these 
CNTs. 
Endothelial cells are highly sensitive to shear stress with the ability to be easily 
oriented [201] as well as the ability to control orientation and migration of endothelial 
cells by distinct fluid flows [202, 203]. Independent to fluid flow, reports show the use of 
localized α4 integrin phosphorylation to align endothelial cells [204], while others have 
discovered laminin gradients affect endothelial alignment to a high degree as well [205]. 
Collagen based nanofibers [206] and topographic cues [207] have also induced migration 
and orientation of endothelial cells without the use of fluid flow which have lead us to 
use aligned CNTs to orient endothelial cells for a variety of applications. With the CNT 
fabricated substrates shown here, our results coincide with previous studies in showing 
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alignment and migration and to this end, we believe this CNT based substrate can be used 
to tune cell growth and migration in a controlled manner. 
 
Figure 2. 3 Immunofluorescent images of HUVECs on CNT substrates. DAPI (blue), 
PECAM (green), F-actin (red) are shown. HUVECs are randomly distributed on CNT 
randomly assembled substrate, either confined by CNTs or spread over CNTs. 
 
Cell adhesion of HUVEC was performed on both randomly assembled CNT 
substrate (Figure 2. 3) and aligned CNT substrate (Figure 2. 4). HUVEC were not in an 
aligned fashion on randomly assembled CNT substrate. HUVEC organized cytoskeleton 
in random orientations and was confined in a small adhesive area. PECAM-1 staining 
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showed a significant lack of cell-cell contact junction indicating cells have limited 
mobility on randomly assembly CNT substrate [208]. Consequently, HUVEC cells were 
able to sense and recognize CNT-ligand conjugates on substrates ash showed in Figure 2. 
3.  
 
Figure 2. 4 Immunofluorescent images of HUVECs on substrates. DAPI (blue), 
PECAM (green), F-actin (red) are stained. HUVECs are able to bind to aligned CNT-
ligand conjugates and show a spread, aligned phenotype along CNTs aligning 
direction. 
 
In contrast, HUVEC behaves an aligned fashion on aligned CNT substrate. As 
shown in Figure 2. 4, immunofluorescent images of HUVECs on aligned CNT substrate 
showed that HUVEC cells adapt to the CNT alignment. PECAM-1 staining showed 
HUVEC cells had distinct cell-cell contact junctions along with aligned CNT direction. 
Cytoskeletal organization was highly stressed towards aligned CNT direction as well. 
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Note that HUVEC cells were able to migrate and orientated on collagen based nanofibres 
[206] and aligned topography [207],  our aligned CNT substrate could provide potential 
capability of controlling vascularization and directing stem cell differentiation to those 
cells which have specific alignment characteristics, e.g. cardiomyocytes and neurons.  
Traditionally maintaining hESC cultures in vitro requires MEF feeder layers and 
manual passaging of individual colonies. This method does not lend themselves to large 
scale production of pluripotent cells for high throughput experiments. Enzymatic 
dissociation of pluripotent stem cells has recently been reported as a method to higher 
scale passaging of pluripotent cells for future clinical possibilities [209-211]. However, 
problems occurred with enzymatic passaging of hESCs. It is hard to maintain hESCs 
within certain size [210, 212, 213]. There is also the possibility of genetic and epigenetic 
changes in hESCs [214-216]. Overcoming these obstacles is harnessing hESC research to 
decipher single cell level interactions. With a homogenous population of hESC single 
cells, it will be feasible to study cell-substrate interactions in greater depth than 
previously. Thus, we are trying to use CNT substrate to bring us closer to decipher hESC-
substrate interactions within highly tunable CNT substrate. 
Fluorescent images of single hESC were showed in Figure 2. 5. hESC adhesion 
experiments were also demonstrated the utility of aligned CNT substrate to be related to 
stem cells research. We studied cell adhesion of H9 cell at single cell culture level to 
demonstrate the ability to selectively bind to a CNT-ligand conjugates and retain initial 
pluripotency. This was preferential over colonies due to the ability to expand hESCs as a 




Figure 2. 5 Fluorescent images of single hESC on CNT substrate. A. Top left 
showing bright field image of single H9 cell line, top right showing vinculin in green 
and DAPI in blue, bottom left showing actin in red and DAPI in blue, bottom right 
showing merged image.  This demonstrates H9 cells are able to bind to CNT 
substrate with normal focal adhesion structure and spreading tendencies. B. Top left 
showing bright field image of single H9 cell line, top right showing Oct4 in green 
and DAPI in blue, bottom left showing actin in red and DAPI in blue, bottom right 
showing merged image. H9 cells are able to attach and spread on CNT substrate 
while retaining initial pluripotency. 
 
Single cells were able to bind to CNT substrate with a small percentage of cells 
being able to fully spread. To test whether CNT substrate affect initial hESC properties 
such as pluripotency, cytoskeletal formation, or spreading tendencies of single ESCs, 
markers for Oct4 and F-actin were labeled with antibodies.  As shown in Figure 2. 5, 
cells retained pluripotency by expressing markers of Oct4 and flattened cell morphology. 
As shown with phase contrast in Figure 2. 5, these cells exhibited a more irregular outline 
showing more prominent filapodia extensions to surrounding CNT-ligand conjugates. 
Focal adhesions were shown to be normal and intact indicating a normal cell phenotype 
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on the CNTs as shown in Figure 2. 5A. This shows the function of the CNT substrate and 
the ability to parse the substrate-hESC interaction in future studies. 
 
2.4.      Conclusion 
  In summary, we have fabricated a substrate patterned with aligned CNT-ligand 
conjugates to be used in a variety of potential applications. We test the utility of HUVEC 
cells and hESC single cells to recognize, attach and bind to CNT-ligand conjugates with 
normal phenotype and function. We found that (A) CNT substrate was able to provide 
focal adhesion binding sites for cell adhesion. (B) Through aligning CNT-ligand 
conjugates, we are able to align cells in unique direction. (C) This study provides 
foundation in specific lineage directing of hESC single cells.  
We have provided a new approach to tune hESC culture at single cell level. This 
would allow us to culture and induce cell differentiation of single hESCs for a better 







Carbon Nanotube-Poly(lactide-co-glycolide) Composite Scaffolds for Bone Tissue 
Engineering Applications 
 
3.1.      Introduction 
Bone has the inherent ability to repair small fractures; however, larger bone 
defects resulting from trauma, tumor resection or muscuoloskeletal diseases heal over a 
long period of time. Orthopaedic surgeons currently employ two approaches to treat bone 
defects: (i) autografts, in which the patient’s own healthy bone tissue is used, and (ii) 
allogenic grafts, in which bone tissue is obtained from another donor. Autografts are 
presently considered to be the best treatment option for their osteoconductivity, 
osteinductivity and osteogenecity [219, 220]. However, the use of autografts is restricted 
by the shortage of supply and need for a secondary surgery. The use of allografts also 
faces major hurdles including the risk of immune response and disease transmission.[221-
224] In addition, long-term storage of allografts renders the bone structurally weak and 
destroys most of the osteoprogenitor cells. In recent years, tissue engineering (Figure 3. 1) 
has been evolving as an alternative strategy to develop bone grafts. This approach relies 
on the use of combinations of specific cell types, growth factors and three dimensional 





Figure 3. 1 Schematic of tissue engineering. In brief, cells are isolated to expand in 
in vitro culture. Next, scaffold with growth factor are recruited to regenerated tissue 
in vitro. Then, the regenerated tissue is transplanted into human body to replace the 
failure tissue. Finally with the successful implantation of regenerative tissue, the 
tissue failure could be cured. 
 
A main focus in musculoskeletal tissue engineering is the design of 3D scaffolds, 
which guide the intricate dynamic cell signaling processes that governing the migration 
of host cells, differentiation of transplanted cells and formation of bone extracellular 
matrix (ECM) [228]. In this context, significant effort has gone to fine tune the nano-
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scale structure and chemistry as well as the mechanical properties of scaffolds in order to 
recapitulate the in vivo natural bone development. 
One important obstacle in construction of engineered tissues is the proper 
perfusion of nutrients and oxygen through scaffolds. To overcome this limitation, highly 
porous scaffolds, through which nutrients can diffuse, are often preferred. However, 
higher porosity may compromise the mechanical properties of scaffolds. Towards 
optimizing scaffold properties, there is a need to establish the correlation between 
structural parameters (eg. pore size and porosity) and mechanical parameters (eg. 
compressive modulus and strength). Bone exhibits strong mechanical properties as it 
provides structure stability for the body and it allows for millions of loading cycles 
throughout a person’s lifetime. The compressive modulus of an adult trabecular bone is 
over 150 MPa; thus, high modulus materials are suitable for bone tissue engineering 
applications. Polymers such as poly(lactic acid) (PLA), poly(glycolic acid) (PGA), their 
copolymers poly(lactic acid-glycolic acid) (PLGA) as well as ceramics such as HA have 
been used to develop 3D scaffolds using various fabrication methods [229-238]. Because 
of their biocompatibility, osteoconductivity, and appropriate range of mechanical 
properties, these materials have received substantial attention for skeletal repair and 
regeneration. 
Surface roughness is another important property that allows for osseointegration 
of scaffolds [72-74]. In general, cells can sense surface topography and adjust their shape 
and cytoskeletal organization accordingly [77, 78]. In the context of bone tissue 
engineering, reports have demonstrated osteoblasts to preferentially adhere to substrates 
with nano-grooves, as compared to substrates with a smooth surface [239, 240]. As an 
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example, Khang et al. showed that the nano and submicron structured Ti surface 
upregulates the expression of osteogenic differentiation markers. Interestingly, peaks of 
2-4 nm in height induced reorganization of cell cytoskeleton, increased cell spreading and 
subsequently enhanced osteogenic differentiation [241]. These studies, all together, 
demonstrate the importance of tuning scaffold surface roughness for desired tissue 
engineering applications. 
We developed an approach to incorporate CNTs into a PLGA scaffold. We 
hypothesized that CNTs will increase the mechanical strength of scaffolds and allow for 
tuning the surface roughness, which in turn increases the osteogenic differentiation and 
bone mineralization. This hypothesis is based on previously published reports 
demonstrating the potential of CNTs to (i) reinforce mechanical strength of 
composites[8], (ii) accelerate the proliferation of cells, and (iii) create nano-scale rough 
substrates leading to improved cell function [34, 101, 242]. To this end, we examined the 
effects of homogenously dispersed CNT density on the structural and mechanical 
properties of composite CNT/PLGA scaffolds. This was followed by an in vitro 
evaluation of MC3T3-E1 osteoblast-like cell proliferation, cytoskeletal organization and 
bone mineral deposition on composite CNT/PLGA scaffolds. The innovative aspects of 
this project include: (i) the development of a scalable method based on the use of CNTs 
to fine tune the nano-roughness of 3D scaffolds, (ii) the establishment of a fundamental 
relationship between the CNTs concentration, homogenous/heterogeneous dispersion, 
degree of aggregation, and mechanical strength in a PLGA polymeric composite system, 
and (iii) introduction of CNT/PLGA composite scaffolds as an osteogenic matrix for 
bone repair.  
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We have demonstrated the ability of CNT containing PLGA scaffolds for bone 
regeneration in this chapter. To the best of our knowledge, previous study has showed 
that for CNT addition increases either stiffness or surface roughness, which in turn 
increases osterogeneis. The great innovative aspect in Chapter 3 lies in that by developing 
a 3D CNT content scaffolds, we were able to coupling the surface roughness and 
mechanical strength together to enhanced osteogenesis. As we confirmed, the increase of 
nano roughness and mechanical strength together help improve osteogensis. 
 
3.2.      Materials and methods 
3.2.1. Synthesis of carbon nanotubes embedded PLGA scaffolds 
The fabrication process was showed Figure 3. 2. CNTs were obtained from 
Nanolab which were 1-5 µm in length and 20 nm in diameter with a purity larger than 
95%. CNT/PLGA scaffolds were fabricated using a solvent casting/particulate leaching 
method. Briefly, 30 mg of PLGA (Lectone, 85:15) was dissolved in 300 μl of 
CNT/dichloromethane solution. A sonication process was used to uniformly disperse 
CNTs in dichloromethane in three concentrations of 1 mg/ml, 3 mg/ml and 5 mg/ml 
before adding PLGA. The mixture of PLGA in CNT/dichloromethane was gently 
vortexed for 60 mins and sonicated for 30 mins, allowing for the PLGA to fully dissolve 
homogenized. Next, the mixture was added into a Teflon mold wells (5.5 mm in diameter 
and 2 mm in depth) with 60 mg of NaCl (Sigma) in diameters ranging from 104 to 214 
μm. Following the evaporation of dichloromethane for 12 hours, the CNT/PLGA 
scaffolds were extracted from the wells of the model, stirred in DI water for 2 days and 
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dried at 37 ⁰C in a vacuum oven. The scaffolds were stored in sterile tubes sealed with 
parafilm until cellular analysis.  
 
 
Figure 3. 2 Schematic of salt leaching method. In general, a mixture of porogen 
and scaffolding materials in certain solvent was homogenized dispersed and 
place in a model. Next, a scaffold without pores were formed in a desired shape 
by evaporation of that certain solvent. Lastly, porogen was extract by another 
solvent which will not dissolve scaffolding materials and left the space for the 





3.2.2. Structural, surface roughness and mechanical characterizations of scaffold 
The morphology and pore structure of CNT/PLGA scaffolds were evaluated using 
scanning electron microscopy (SEM). In brief, scaffolds were attached to sample stubs 
and sputter coated with gold. In general, vacuum at 100 Torr has been applied with Ar air 
blowing into the vacuum chamber. Au was coated for 30 seconds for the purpose of 
conductive. The samples were viewed under SEM at an accelerating voltage of 10kV.  
 Atomic force microscopy (AFM) in combination with light microscopy was used 
to measure the surface roughness of and the degree of CNT aggregation in PLGA films 
containing CNTs at various concentrations. Briefly, PLGA was dissolved in a 
CNT/dichloromethane solution to give the total CNT concentrations of 1%, 3% and 5%. 
CNT/PLGA solution (100 μl) was dipped onto a 1 cm × 1 cm cover slip drop wisely. This 
was followed by a 24 h drying at room temperature in a sealed desiccator. AFM 
measurements on multiple locations of CNT/PLGA films were obtained using a 
NanoScope IIIA MultiMode AFM (Veeco) with contact mode. A scan field of 10 µm × 
10 µm with a scanning rate of 1 Hz was used for these measurements. The data was 
analyzed using NanoScope imaging software. 
The mechanical strength of three groups of CNT/PLGA scaffolds (5 mm in 
diameter and 2 mm in height) with various CNT densities (1%, 3%, 5%) were compared 
and controls were carried out using PLGA scaffolds. Compressive modulus testing was 
conducted using a mechanical testing machine (ElectroForce 3200) at room temperature 
in unconfined compression at 0.05 mm/sec between parallel nonporous plates while 
compressive force and displacement were recorded. Based on the monitored strain (σ) 
and stress (ε), the compressive modulus (E) was determined using the equation: E=σ/ε. 
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3.2.3. Cell seeding 
In order to sterilize, scaffolds were immersed in 70% ethanol for 10 min, rinsed 
three times with sterile phosphate-buffered saline (PBS) and exposed to UV light for half 
an hour on each side. Next, scaffolds were transferred into 24-well culture plates and 
seeded with 20,000 MC3T3-E1 (ATCC) osteoblast-like cells per scaffold. Cells were 
cultured in α-MEM (Gibco) supplemented with 3 mmol/l glycerophosphate disodium 
(Sigma), 10 μg/l ascorbic acid (Sigma), 1% penicillin-streptomycin (Invitrogen) and 10% 
fetal bovine serum (FBS) (Invitrogen). Samples were maintained in a humidified 
incubator at 37°C with 5% CO2.  
 
3.2.4. Cell attachment, growth, and morphology 
At predetermined time points, cell morphology was evaluated using SEM. Cells 
on scaffolds containing various CNT densities were fixed in 1% and 3% glutaraldehyde 
(Fisher) for 1 h and 24 h, respectively. The scaffolds were dehydrated sequentially by a 
series of ethanol concentrations (10%, 30%, 50%, 70%, 90%, 95%, and 100%) for 15 
mins each. Scaffolds were then allowed to dry overnight, coated with gold/palladium, and 
observed under SEM. For Au coating, For a 30 seconds of Au coating, a vacuum at 100 
Torr has been applied with Ar air blowing into the vacuum chamber.  
Cell proliferation on scaffolds was assessed using 3-(4,5-Dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) (Alpha Aesar) calorimetric assay. In brief, 
scaffolds were washed with PBS, transferred into a new 24 well plate containing 1.5 ml 
of fresh culture medium and 300 μl MTT/PBS solutions and incubated at 37°C for 5 h. 
This was followed by the removal of medium/MTT solution and addition of 1.5 ml 
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dimethyl sulfoxide (DMSO) (Fisher) into each well. The resulting solution was diluted in 
a 2:1 ratio using DMSO and the absorbance was read at 550 nm using a Tecan 
SpectroFluo Plus reader. The cell number per scaffold was normalized through a 
calibration curve. 
We used F-actin staining to confirm the cytoskeletal formation of cells on 
CNT/PLGA scaffolds. Briefly, cells on scaffolds were fixed at room temperature in 10% 
formalin for 30 min. After a 3X wash, cells were permeabilized using a 0.1% Triton X 
solution for 5 min. Cells were washed 3X with PBS and blocked using a 1% bovine 
serum albumin (Sigma) (BSA) solution for 1 h. TRITC-conjugated phalloidin (1:40) 
(Invitrogen) was used to stain the cytoskeletal protein actin for 1 h followed by nuclei 
staining with 4’-6-diamidino-2-phenylindole (1:30) (DAPI, Invitrogen). Stained cells 
were visualized using a Nikon Eclipse 80i microscope.  
 
3.2.5. Assessment of osteogenic differentiation 
Osteogenic differentiation was assessed by monitoring the expression of alkaline 
phosphatase (ALP) and deposition of calcium by cells cultured on scaffolds. This was 
evaluated for CNT/PLGA scaffolds with CNT densities of 1%, 3% and 5% while PLGA 
scaffolds were considered as a control. 
ALP activity of the cells was measured quantitatively using an alkaline 
phosphatase substrate kit (BioRad). The basic of this method is to convert p-nitrophenyl 
phosphate into p-nitrophenyl in the presence of ALP where the rate of p-nitrophenyl is 
proportional to ALP activity. Cells were lysed with 1% Triton X-100 in autoclaved water 
for 5 min and then the cell lysates were collected and stored at -80⁰C. Upon thawing, 100 
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μl of the cell lysate was added to 400 μl of p-nitrophenyl phosphate substrate and buffer 
solution mixture and incubated at 37 ⁰C for 30 min. This was followed by addition of 500 
μl of 0.4 mol/l sodium hydroxide to stop reaction. The production of p-nitrophenyl was 
determined by monitoring the absorbance at 405 nm using a Beckman Coulter DU 730 
UV/Vis spectrometer. The ALP activity was normalized by the number of cells on each 
scaffold. 
ALP activity staining of cells on scaffolds was also accomplished using an 
alkaline phosphatase kit #85 (Sigma). Briefly, samples were fixed in 10% formalin 
solution for 30 min and washed 3X with PBS. The staining solution was prepared by 
mixing the content of Fast Blue capsule in napthanol for 30 min. This was followed by 
3X wash in PBS and incubation in the Mayer’s Hematoxylin solution for 10 min. Stained 
cells were then photographed using a Nikon Eclipse 80i microscope. 
The calcium deposition by cells was quantified using O cresolphthalein 
complexone (Sigma) method. In brief, at predetermined time points, the media was 
removed. Following a 3X wash with DI water quickly, samples were homogenized with 
0.6 mol/l hydrogen chloride. This was followed by 4 h of shaking at 4 oC to extract 
calcium. Next, 37.8 ml of 2-amino, 2-methyl, 1-propanol (AMP) was dissolved in 150 ml 
DI water and adjusted to pH 10.4 by 6 mol/l HCl in the final volume of 250ml. AMP 
buffer were stored in dark at room temperature until use. Color reagent was prepared as 
describe: HCI (36.5%) (15 ml) was added to a 250 ml flask containing about 25ml of DI 
water. 25 mg 0-cresolphthalein complexone (Sigma) powder was added into the above 
prepared HCl solution. 250 mg of 8 hydroxy-quinoline (Sigma) was added as well. The 
color reagent was make up to 250 ml with DI water and stored in dark at room 
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temperature until use. A series of calcium in different concentration in DI water was 
prepared (1 mg/ml, 3 mg/ml, 5 mg/ml, 7 mg/ml and 10 mg/ml) as control. 
Then, Tested samples and prepared calcium solution of different concentration, 
100 µl each, were placed in 6 well plate with 2 ml AMP buffer and 2 ml color reagent. 
Incubated the 6 well plate at room temperature for 15 mins. And the absorbance was read 
using a spectrophotometer at 570 nm. A calibration curve was plotted by prepared 
calcium solution of different concentration. Calcium content of all tested samples were 
calculated accordingly. 
Extracellular matrix mineralization was assessed using Alizarin Red S staining 
too. In brief, samples were fixed in 10% formalin for 30 min followed by a 3X wash in 
DI water. Next, samples were incubated for 5 min in 0.02 mg/ml Alizarin Red S (Sigma) 
staining solution (pH: 4.2-4.5). Samples were washed in ethanol and photographed under 
a Nikon microscope.  
 
3.2.6. Statistical analysis 
Five samples were analyzed per condition. Data in graphs represents mean ± 
standard deviation (SD). Comparison between the two means was determined using the 








3.3.      Results and discussion 
3.3.1. Characterization of scaffolds 
 
Figure 3. 3 SEM and digital camera images of CNT/PLGA composite scaffolds.  (A) 
Control PLGA scaffold; (B) 1% CNT incorporated PLGA scaffold; (C) 3% CNT 
incorporated PLGA scaffold; (D) 5% CNT incorporated PLGA scaffold; (E) 
Photograph of PLGA and CNT/PLGA scaffolds made by salt leaching/particulate 
leaching method. White scaffold on the left is a PLGA scaffold and black scaffold on 
the right is a 1% CNT incorporated PLGA scaffold. All scaffolds were 5.5 mm in 




Figure 3. 3 shows SEM images of PLGA (Figure 3. 3A), and 1% CNTs (Figure 3. 
3B), 3% CNTs (Figure 3. 3C) and 5% CNTs (Figure 3. 3D) incorporated PLGA 
scaffolds, respectively. All scaffolds were highly porous with an interconnected pore 
structure. The diameters of cubic pores ranged between 100 μm to 200 μm, as determined 
by the NaCl particle size used in scaffold synthesis. Figure 3.3E showed a photograph of 
PLGA and 1% CNTs incorporated PLGA scaffold. Scaffolds made from pure PLGA 
appeared to be a white disk with a diameter of 5.5 mm and height of 2 mm while the 
incorporation of 1% CNTs changed the color of scaffold to black.  
Bone tissue engineering strategies rely on the ability to develop 3D porous 
scaffolds with mechanical, structural and ECM compositional characteristics of natural 
bone. Bone tissue is organized into 5 different tissue type categories: (i) the 
macrostructure which is composed of cortical and cancellous bone, (ii) the microstructure 
which is made up of osteons, haversian systems, and trabeculae, (iii) the sub-
microstructure made up of lamellae, (iv) the nanostructure composed mainly of collagen 
fibers and (v) the sub-nanostructure which has components such as mineral, collagen, and 
other organic proteins [243]. Recreation of the complexity of native bone is major 
challenge in scaffold based bone tissue engineering approaches. Further studies are 
warranted to elucidate the individual role of scaffold design parameters on the rate of in 








Table 3. 1 Surface roughness of PLGA and CNT incorporated PLGA films 
as measured by AFM. The addition of CNTs resulted in an increase in the 
roughness of films. 
Substrate RMS (nm) 
PLGA film 7.17±1.62 
1% CNT incorporated PLGA film 43.95±10.74 * 
3% CNT incorporated PLGA film 103.05±9.93 * 
5% CNT incorporated PLGA film 169.17±12.72 * 
* represents significant difference in surface roughness of CNT/PLGA 




Figure 3. 4 AFM images of PLGA and CNT incorporated PLGA films. (A) Control 
PLGA film; (B) 1% CNT incorporated PLGA film; (C) 3% CNT incorporated PLGA 
film; (D) 5% CNT incorporated PLGA film. The addition of CNTs led to an increase 
in surface roughness and aggregation of nanotubes.  
 
The research work described in this manuscript focuses on the design and 
development of CNT/PLGA scaffolds for bone tissue engineering applications. It was 
hypothesized that the addition of CNTs to PLGA would combine the enhanced 
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mechanical competence of porous scaffolds with the benefits of the increased nano-scale 
surface roughness. A rationale for this work was based on recently published reports 
demonstrating the extraordinary ability of CNTs to reinforce polymeric composites. This 
unique capability stems from high surface to volume ratio and modulus of CNTs [1, 2]. 
Figure 3. 4 demonstrated the representative AFM images of PLGA and 
CNT/PLGA films. Our results demonstrated a direct correlation between the CNT 
concentration and surface roughness. The addition of CNTs would significantly increase 
the surface roughness of CNT/PLGA composites. Table 3.1 summarized the average 
calculated roughness for PLGA and PLGA/CNT films. We observed that the roughness 
increases from 7.17±1.62 nm to 43.95±10.74 nm with the addition of 1% CNTs. We 
hypothesized that the degree of aggregation and homogeneity in dispersion of CNTs 
define the roughness. To confirm this hypothesis, we performed light microscopy of 
PLGA films containing CNTs at various ratios. Our results, shown in Figure 3. 4, 
demonstrated a homogenous dispersion of single CNTs at 1% ratio and bundling of 
CNTs at 3% and 5% ratios to a degree that individual nanotubes become undetectable.   
Another major motivation for this study stems from the previous reports 
demonstrating the osteogenic properties of CNTs in 2D and 3D systems. In this context, 
several groups have attributed the enhanced osteoblast proliferation and unregulated rate 
of differentiation to the increased surface roughness resulting from the addition of CNTs 
[108-110]. In particular, Zanello et al. recently demonstrated that osteoblasts change 
morphology and express plate-shaped crystals in the presence of CNTs [34]. In another 
study, osteoblasts exhibit an osteocyte-like morphology as compared to cells cultured on 
a glass surface and expressed a higher level of osteogenic differentiation and maturation 
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[104]. The osteogenic effects of nano-roughness has been shown in other systems in 
which nanoparticle coated surfaces promoted differentiation through the activation of 
mitogen-activated protein kinase (MAPK) pathway [106]. In line with these findings, 
Kim et al. demonstrated MAPK to be the dominating pathway in regulating the 
osteogenic response of cells to surface roughness on Ti substrates. This effect has also 
been demonstrated in 3D scaffolds, where Edward et al. demonstrated a higher degree of 
osteogenic differentiation on eletrospun PLGA fibers containing CNTs [112].  
We used AFM to confirm that CNT incorporation affects the surface roughness of 
scaffolds. We accomplished this analysis in films since the AFM measurements in 2D 
yields a more consistent information than 3D scaffolds. Films of PLGA containing CNTs 
at concentrations of 1%, 3% and 5% were chosen for this study and the results were 
measured in terms of average roughness in nanometers. As depicted in Figure 3. 4 and 
Table 3. 1, we observed an increase in roughness of the PLGA films with the addition of 
CNTs. This trend was consistent with a previously published report by Tseng et al. in 
which they demonstrated the surface roughness of CNT/Polyimide films to increase with 
the concentration of CNTs [244]. To illustrate the mechanism behind the impact of CNT 
concentration on roughness, we used light microscopy to visualize nanotubes within the 
films. At 1% CNT/PLGA ratio, we observed individual nanotubes to create wrinkles 
within the PLGA film in all directions leading to an enhanced roughness. With the 
increase of concentration to 3% and 5%, CNTs started to aggregate at a higher rate. We 
postulate that this phenomenon is responsible for the increased surface roughness of the 




Figure 3. 5 Compressive modulus of PLGA and CNT incorporated PLGA 
scaffolds. * denotes significant difference when CNT/PLGA scaffolds, as 
compared to PLGA scaffold (p<0.05) the mechanical strength has been 
increased by addition of CNTs. However, CNT content more than 1% leads a 
slight decrease in Young’s modulus compared to 1%. 
 
 The mechanical properties of scaffolds were assessed by compressive modulus 
testing. Interestingly, as shown in Figure 3. 5, CNT/PLGA scaffolds demonstrated a 
significantly higher compressive modulus than control PLGA scaffolds. The average 
compressive modulus of PLGA, 1% CNT/PLGA, 3% CNT/PLGA and 5% CNT/PLGA 
scaffolds were 1.75±0.20 MPa, 6.36±0.55 MPa, 6.0±0.06 MPa and 5.51±0.14 MPa, 
respectively. The addition of 1% CNTs into the PLGA scaffolds resulted in 3.6 fold 
increase in compressive modulus demonstrating the potential of CNTs as to fabricate 
composite scaffolds with desired mechanical strength. 
In this study, we used solvent casting/particulate leaching to develop scaffolds. A 
major advantage of this fabrication method is that it allows for control over the porosity 
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and pore size through the use of NaCl particles with selective size ranges [245]. In line 
with our hypothesis, the results demonstrated a 3.4 fold increase in compressive modulus 
with the addition of 1% CNTs to PLGA scaffolds. Interestingly, the higher CNT ratios 
led to a decrease in mechanical strength. We attribute the reduction in mechanical 
strength of scaffolds to the aggregation and heterogeneous distribution of CNTs within 
the scaffolds. The tendency of CNTs to aggregate stems from their nano-structure, van 
der Waals interaction and limited dispersibility [246] It is important to note that this 
phenomenon has been also observed in other studies on mechanical properties of 
composites. For instance, Narimissa et al. showed a gradual decrease in Young’s 
modulus of graphite/PLA nanocomposite due to aggregation of graphite [247]. In another 
study, Saotome et al. demonstrated a reduction in modulus with as larger fullerene nano-
particple aggregates formed within the polycarbonate nanocmposites [248]. Take a step 
forward, we used percolation theory to explain the mechanical behavior of our scaffolds. 
This theory allows for calculating the threshold that describes the critical volume fraction 
separating the two phases in the mixture. Interestingly, the percolation threshold for 
CNT/polymer system is dependent on size and distribution of CNTs [249, 250]. 
Specifically, the percolation threshold for a rod-like filler for mechanical enhancement 
could be calculated according to this equation: Vfc=0.7/(L/d). Where L and d represents 
length and diameter of a filler [251, 252]. Since our CNTs are 1-5 um in length and 20-40 
nm in diameter, the calculated threshold is about 1.2%. Consequently, a drop of Young’s 





3.3.2. In vitro evaluation of CNT/PLGA scaffolds 
 
Figure 3. 6 Cell attachment on PLGA and CNT/ PLGA films after 1 day of cell 
seeding. * denotes significant difference in cell number on CNT incorporated 
PLGA scaffolds compared to PLGA scaffolds (p<0.05) the cell number adhere 
to film has been increased by addition of CNTs. However, CNT content more 




To assess the effect of CNTs on initial cell attachment, we measured cell number 
on PLGA, 1% CNT/PLGA, 3% CNT/PLGA and 5% CNT incorporated PLGA films after 
4 hours of cell culture (Figure 3. 6). Average cell number attached on films showed an 
increase with the addition of CNTs to PLGA. Cell number appeared to be highest on 1% 




Figure 3. 7 SEM images of MC3T3-E1 osteoblast morphology and growth on PLGA 
(A and C) and 1% CNT/PLGA scaffolds (B, D) at days 7 and 21 respectively. No 
significant difference in cell morphology was noticed between the two groups. 
 
Cell morphology and growth on scaffolds were visualized using SEM (Figure 3. 
7). Cells first attached to the wall of pores and formed cell bridges between cell walls. All 
of the scaffolds were fully confluent after 7 days meanwhile pores could still be seen. At 





Figure 3. 8 MC3T3-E1 osteoblast proliferation on TCPS, PLGA and CNT 
incorporated scaffolds. *, + and ^ represents significant difference in cell 
proliferation on CNT/PLGA scaffolds compared to PLGA scaffold at the same 
time point at significance levels of p<0.05, p<0.1 and p<0.5, respectively. 
 
Cell proliferation on 3D scaffolds was assessed quantitatively using MTT assay, 
as presented in Figure 3. 8. Four groups of PLGA, 1% CNT/PLGA, 3% CNT/PLGA and 
5% CNT/PLGA scaffolds were considered for this study. Tissue culture polystyrene 
(TCPS) control group was included to confirm the status of cell culture conditions. The 
data presented growth in cell number as a function of time for all the groups. Strikingly, 
the incorporation of CNTs into the scaffolds resulted in a significant increase in cell 
proliferation for all time points and reached a plateau at day 28. Consistently in all time 
points, the maximum increase in cell proliferation as compared to PLGA scaffolds was 





Figure 3. 9 Immunofluorescent staining of (A-B) nuclei, (C-D) cytoskeletal 
protein actin, and (E-F) actin-nuclei double staining of MC3T3-E1 
osteoblasts cultured on PLGA (left column) and 1% CNT/PLGA (right 
column) scaffolds for 21 days. No significant difference in cell morphology 
was noticed between the two groups. 
 
Cell cytoskeletal organization and morphology within the scaffolds were 
visualized via immunofluorescent staining with nuclei DAPI and cytoskeleton protein 
actin. Figure 3. 9 illustrates cell nuclei and actin double staining of cells cultured on 
PLGA and composite CNT/PLGA scaffolds. We observed that cells proliferated on the 
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surface and within the pores of scaffolds. There was not a noticeable difference in 
cytoskeletal organization between the control and CNT incorporated scaffolds. 
 
Figure 3. 10 Alkaline phosphatase activity and calcium 
expression of MC3T3-E1 osteoblasts on PLGA and 
CNT/PLGA scaffold. *, + and ^ represents significant 
difference in ALP activity and calcium expression by 
cells on CNT/PLGA scaffolds compared to cells on 
PLGA scaffolds at the same time point at significance 
levels of p<0.05, 0.1 and 0.5, respectively. A slight 
increase of calcium content was observed in first two 
weeks and a sharp leap of calcium content in after that. A 
moderate increase of ALP activity was observed through 




Osteogenic differentiation of cells was assessed by quantifying ALP activity and 
calcium content combined with qualitative Alizarin red mineral and ALP staining. Figure 
3. 10A showed ALP expression level by cells grown on control PLGA scaffolds as well 
as scaffolds containing 1%, 3%, and 5% CNTs.  
 
Figure 3. 11 (A-B) Alizarin red S staining and (C-D) alkaline phosphatase staining of 
MC3T3-E1 ostoblasts on PLGA (left) and 1% CNT/PLGA scaffold (right) at day 21. 
Calcium and ALP staining were showed positively, respectivly.  
 
For all groups, ALP expression increased as a function of time. While the addition 
of CNTs resulted in enhanced osteogenic differentiation, the group containing 1% CNTs 
demonstrated the highest level of ALP expression. These results were consistent with the 
results of calcium content quantification (Figure 3. 10B). The data demonstrated an 
increase in calcium content on control PLGA scaffolds as well as PLGA scaffolds 
containing CNTs as a function of time. Strikingly, 1% CNT/PLGA scaffolds 
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demonstrated the highest amount of calcium with 1.5 fold higher level than control 
PLGA scaffolds after 28 days of culture.  
We confirmed the mineral deposition and ALP expression by cells cultured on 
PLGA and 1% CNT/PLGA scaffolds, as demonstrated in Figure 3. 11. It was observed 
that cells express ALP enzyme and deposit mineral on the surface and within the pore 
spaces of scaffolds. Interestingly, the addition of CNTs to the scaffolds resulted in a 
faster rate of mineralization and higher rate of ALP expression by cells. These results all 
together demonstrate that CNTs enhance early stage osteogenic differentiation and late 
stage mineralization of osteoblastic cells on 3D PLGA scaffolds. 
In line with other published reports, our in vitro results demonstrated a higher 
degree of MC3T3-E1 osteoblast-like cell adhesion and proliferation rate on PLGA 
scaffolds containing CNTs. The decrease of number of cell attachment accompany with 
more addition of CNT was due to that agglomeration of CNTs.  More dispersed CNTs are 
preferred for cell attachment. Moreover, large agglomeration will also decrease the 
available surface area for cell attachment as well. Progressive osteoblast proliferation was 
observed throughout the scaffold 3D structure and resulted in the formation of cellular 
extensions covering the entire scaffolds and filling the pore spaces. Cell growth 
quantification results were consistent with the immunofluorescent images of actin 
cytoskeleton in showing osteoblasts preserved cellular structure integrity throughout the 
scaffolds. When exposed to the differentiation media, cells underwent osteogenic 
differentiation in 28 days on both control PLGA and CNT/PLGA scaffolds. Our scaffolds 
shows a good biocompatibility to MC3T3-E1 osteoblast-like cells. 
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The extent of differentiation was assessed through quantification of ALP activity 
and calcium content combined with qualitative Alizarin red mineral and ALP staining. 
ALP activity is an early marker of osteogenesis, which usually dominates in the first two 
weeks. Calcium content is the late marker for osteogenesis, which usually dominates after 
two weeks. We did observed a slow increase of calcium content on Day 7 and Day 14 
and a sharp leap of calcium content in after that on Day 21 and Day 28. However, we 
didn’t observe any ALP activity drop on Day 21 and Day 28. This was because the cells 
were mature outside from inside at a different rate. Cells in the middle of scaffold were 
migrated slowly into and need more time mature due to oxygen and nutrition limitation.  
Moreover, our results collectively showed that the presence of CNTs led to a 
significant elevation in expression of osteogenic markers. This was manifested in 
quantified ALP and calcium content measurements as early as day 7. Interestingly, 
scaffolds containing 1% CNT stimulated the growth and differentiation of osteoblastic 
cells at the highest rate. The mechanism of the stimulatory effects of CNTs and inhibitory 
effects of high CNT loading is yet to be determined. However, this can be attributed to 
the higher surface roughness and stiffness as well as the excess bonding of growth factors 
to CNTs. Further studies are warranted to elucidate the mechanisms by which CNTs 
modulate protein adsorption and the consequent stem cell response to exogenous 
adsorbed growth factors.   
The enthusiasm for the biomedical applications of CNTs has been dampened for 
toxicity concerns. In general, the toxicity of CNTs has been reported to be function of 
high surface area and intrinsic surface properties [253]. A recent report by Donaldson et 
al. demonstrated that CNTs are harmful to lung and illicit immunological responses [254]. 
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Further studies by this group showed that long term inhalation of CNTs will cause 
pulmonary tumors. In another report, the fullerene distributed in tissues accumulated 
rapidly in liver and spleen [255]. However, recent work by Mikael et al. suggested that 
CNTs in low concentration and high purity evoke minimum cytotoxicity [256]. 
Tremendous effort has gone to characterize the nature of CNTs toxicity and modify the 
surface properties of CNTs to diminish their adverse effects. An approach to accomplish 
this goal is the functional modification of CNTs to enhance dispersion in physiological 
solutions as well as excretion of CNTs from human body. Singh et al. recently 
demonstrated that CNTs functionalized with carboxylate and hydroxyl groups had 
varying affinities for liver, kidney, spleen and bone, and can be cleared through renal 
excretion route [257]. Our observations in this study provide the proof of principle for the 
use of CNTs combined with osteoblasts in treatment of bone disorders. A future 
extension of this study will include the modification of CNTs to diminish toxicity side 
effects. 
Another future direction of this research involves studies on how to control the 
orientation of CNTs within 3D scaffolds. Alignment allows for control over the extent of 
cell spreading and regulation of phenotype. This has been demonstrated in 2D 
environments where the orientation of CNTs distributed on a surface impacted the 
directional migratory behavior as well as osteogenic differentiation of MSCs. The 
incorporation of CNTs also provides an opportunity to regulate phenotypic expression 
and lineage specification of stem cells by electrical cues. Earlier attempts to accomplish 
this goal led to the fabrication of CNT-based nanodices for neural as well as cardiac 
electrical stimulation [258, 259]. 
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3.4.      Conclusion 
In this study, mechanically competent CNT/PLGA scaffolds were fabricated 
through a uniform dispersion of CNT in PLGA/dichloromethane solution followed by a 
solvent casting and particulate leaching step. The incorporation of CNTs allowed for 
tuning the mechanical strength without compromising the porous architecture of 
scaffolds. The in vitro potential of CNT/PLGA composite scaffolds for bone tissue 
engineering was evaluated by monitoring the behavior of MC3T3-E1 osteoblasts. Our 
results demonstrated that the addition of CNT to PLGA scaffolds leads to a significant 
increase in adhesion, growth and osteogenic differentiation of cells. We were able to 
confirm the coupling of matrix stiffness and mechanical strength to enhanced 
osteogenesis in 3D environment. Interestingly, scaffolds containing 1% CNT 
demonstrated the highest level of in vitro bone mineralization due to a more uniform 
distribution of CNTs throughout the PLGA scaffolds. These findings all together 
demonstrate CNTs to be a powerful tool in scaffolds design in stem cell based tissue 
engineering. A more detailed study is warranted to delineate the signaling mechanisms by 







PLGA-Carbon Nanotube Conjugates for Intercellular Delivery of Caspase-3 into 
Osteosarcoma Cells 
 
4.1.      Introduction 
Cancer is a principal concern in today’s health care treatment with more than 10 
million cases each year [260]. Oncologists generally utilize physiological intervention as 
well as chemical and radioactive therapeutics to treat different forms of cancer. The 
drawbacks to the current therapeutics are the removal or necrosis of healthy tissue in 
addition to the tumor tissue. These side effects are one of the major concerns for 
traditional cancer treatments. To this end, targeted drug delivery has paved another 
avenue in potential cancer therapy in recent years. The Food and Drug Administration 
(FDA) approved clinical gene therapy in the 1990s [79] and in experimental and clinical 
stages has since demonstrated the promise of drug delivery in curing human diseases. 
Retrovirus [81], adenovirus [82] and adeno-associate [83] viral vectors are the major 
types of gene vectors used in research today. Although viral vectors are efficient in both 
delivery and transduction of cells, there are concerns that these viruses are sourced from 
lethal diseases such as human immunodeficiency virus (HIV) and human T-cell 
lymphotropic virus (HTLV). A safe, inexpensive, and effective vector has yet to be 
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fabricated for use in gene therapy. Therefore, developing these safe and efficient delivery 
systems in a controlled manner is a major focus and challenge in research [80].  
The enhanced permeability and retention (EPR) effect, which is inherent to tumor 
biology, can allow nano-sized drug carriers to accumulate, retain, and release drugs due 
to the fact that tumors have leaky blood vessels and poor lymphatic drainage [261]. In 
further researching nano-sized drug carriers, scientists have been able to begin to widen 
the window into the dark room of cancer therapy. The use of nano-sized drug carriers has 
a few key advantages including the protection of delicate drugs, enhanced absorption in 
selective tissues, controlled drug distribution profile, and enhanced intracellular 
penetration [123]. Thus, researchers have taken initiative and developed several methods 
to fabricate nano-sized drug delivery carriers. 
Polymers and lipids have garnered the most attention thus far as materials for 
drug delivery. Synthetic polymers such as poly (ethylene glycol) (PEG) [84], poly (lactic 
acid) (PLA) [85] and PLGA [86] as well as natural polymers such as chitosan [87], 
collagen [88], gelatin [89] or lipids [262] can be fabricated as nanoparticles, liposomes, 
and micelles to deliver molecules by either chemical modification or physical absorption. 
Drugs are able to be released in a controlled manner due to either surface and bulk 
degradation or phase transition principles. However, there are concerns with these due to 
immune responses dealing with the heterogeneity of the materials used as well as the low 
transfection efficiency and specificity. In noting this, we sought to develop a highly 
efficient non-viral vector drug delivery system utilizing CNTs. 
 CNTs [2], silicon nanowires [263], gallium nanotubes [264], boron nitride 
nanotubes [265], titanium oxide nanotubes [266] and zinc oxide nano-rods [267] have 
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received an overwhelming amount of support and enthusiasm in biomedical research. 
CNTs are made of a layer of grapheme [268] and have been used to shuttle several 
different biological molecules, ranging from small drug molecules [125] to 
biomacromolecules such as proteins [127], DNA [128, 269] and RNA [130] into different 
types of cells via endocytosis efficiently[131]. Ricin A was also delivered into various 
cell line with conjugation of CNTs and induce cell death. Other than cell proliferation 
inhibition and induction of cell death, DNA plasmids were also delivered into cells and 
enhance certain gene expression.  CNTs are able to easily penetrate the cells and give the 
opportunity to transport this biological cargo across the cell membrane due to an 
extremely high aspect ratio. However, health concerns have hampered the practical 
application of using inorganic CNTs in biological applications thus far. Toxicity issues 
still raise doubts about the practical applications of CNTs due to the intrinsic toxicity 
caused by a high surface area and hydrophobicity [253]. However, toxicity concerns may 
not be a critical issue in cancer therapy due to that (a) EPR effect will accumulate 
nanoparticles in tumor tissue only; (b) The potential toxicity of CNTs would be 
acceptable due to cancer therapy target on killing cancer cells; and (c) CNTs at small 
amounts or functionalized with other molecules have shown to evoke minimum toxicity 
to normal cell line [256, 257]. Therefore, functionalization of CNTs can prove to be a 
successful path to protein and gene therapy. For instance, Liu et al. have been able to 
successfully deliver siRNA with phospholipid PEG (PL-PEG) functionalized CNTs into 
tumor cells and tissue to inhibit tumor cell proliferation, tissue ingrowth, and CXCR4 
expressions both ex vivo and in vivo [132-134]. siRNA was released by breaking the S-S 
bond, which attached the siRNA to PL-PEG. Other pristine CNT based delivery vectors 
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are able to rely on diffusion to unload biological cargoes [127, 128, 130, 269]. Although 
the cellular uptake mechanism may differ depending on the functionalization and size of 
CNTs [124], thus far the researchers have been unable to control the release profile in a 
specified manner. 
In this study we hypothesized a method to engineer a novel CNT based delivery 
vector functionalized with a degradable PLGA coating. Through degradation of PLGA, 
transcription factors are able to be released in a controlled manner and tune cell behavior. 
Significant advantages to our proposed system include the ability to transfect cells 
efficiently with the unique needle-like shape of CNTs, reduce cytotoxicity of pristine 
CNTs through a biocompatible PLGA coating, and program protein release times by 
controlling the degradation profiles of the PLGA. 
 
4.2.      Materials and methods 
4.2.1. Carbon nanotube carboxylation 
CNTs (0.2g) were purchased from Nanolab Inc. with an average length of 1-5 
µm, diameter of 15±5 nm, and purity higher than 95% was added into a single neck glass 
flask with 200 ml 70% nitric acid (Fisher). For carboxylation of CNTs, CNTs were 
homogenously dispersed in nitric acid by sonication for 60 minutes at ambient 
conditions. A condenser reflux apparatus was followed to equip on top of single neck 
glass falsk to prevent CNTs in nitric acid from drying out. A silicon oil bath was set up to 
heat up the oxidation experiment. The reaction temperature was set at 120 oC for 12 
hours. The reaction was quenched by addition of 200 ml deionized (DI) water. The 
mixture was filtered by 0.45 µm cellulose filter paper (Fisher), washed with DI water to 
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neutral pH, and dried at 80 oC  overnight [175]. The black leftover on filter paper was 
stored in a glass vial sealed with parafilm in a desiccator until use. 
 
4.2.2. PLGA functionalization 
Carboxyl CNTs (50 mg), as prepared in 4.2.1., were homogeneously dispersed in 
50 ml dimethylformamide (DMF) (Fisher) by sonication for 2 hours at ambient 
conditions. A total of 2 ml oxalyl chloride (Acros) was added drop wisely under N2 and 
stirred in ice water for 2 hours with a magnetic stirrer. This mixture was stirred for 
another 2 hours at room temperature. A CNT-acyl chloride has been formed. Then, the 
mixture was transferred into a silicon oil bath at 70 oC and stirred overnight to remove the 
excess of oxalyl chloride. PLGA (0.5 g) (75:25) (Lactel) was then added and stirred at 
100 oC for 5 days. CNT-PLGA was then formed by that chloride of CNT-acyl chloride 
was replaced by PLGA through a nucleophilic reaction. Finally, the CNT-PLGA 
containing solution was cooled down, filtered by 0.45 µm cellulose filter paper (Fisher), 
and washed with DMF, ethanol (Decon Labs), and DI water. The PLGA linked CNTs 
(CNT-PLGA) were the black leftover on the filter paper and were dried at 80 oC 
overnight, collected and stored in a glass vial sealed with parafilm in a desiccator [177]. 
 
4.2.3. Protein attachment 
CNT-PLGA (100 µg) was dispersed in 0.5 ml of 2-(N-Morpholino)ethanosulfonic 
acid (pH 5.6) (MES) (Acros) buffer under sonication for 1 hour at ambient conditions. 
0.25 ml of 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (0.2 mol/L) 
(EDC) (Acros) and 0.25 ml of N-Hydroxysuccinimide (0.1 mol/L) (NHS) (Acros) in 
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MES solution were added to the activated carboxylate groups [170, 171]. EDC reacts 
with a carboxyl group on CNT-PLGA, forming an amine-reactive O-acylisourea 
intermediate. This intermediate may react with an amine on proteins, yielding CNT-
PLGA-protein conjugates. However, the intermediate is also susceptible to hydrolysis, 
making it unstable and short-lived in aqueous solution. The addition of NHS stabilizes 
the amine-reactive intermediate by converting it to an amine-reactive NHS ester, thus 
increasing the efficiency of EDC-mediated coupling reactions. Finally, the amine-
reactive NHS ester intermediate has sufficient stability to form CNT-PLGA-protein 
conjugation in aqueous solution. 
The mixture was washed with PBS and centrifuged in a 100 KDa molecular 
weight cutoff centrifugal filter (Millipore) to remove EDC and NHS at 5000 g three times 
for 30 mins. Then, 5 µg of protein, either bovine serum albumin (BSA) (Sigma), 
fluorescent BSA (fBSA) (Sigma), or caspase-3 (CP3) (BD) was added into the CNT-
PLGA/PBS solution at 4 oC overnight. The mixture was finally washed and centrifuged 
in a cutoff filter to remove un-conjugated protein six times at 5000 g for 30 minutes 
[171]. The protein conjugated CNT-PLGA (CNT-PLGA-CP3/BSA/fBSA) solution was 
collected and stored at -20  oC. 
Pro-Ject protein transfection kit (BD) was used as a reference. Liposomes 
nanoparticles were fabricated through the commercial manual. Note that the actual 
protein amount dosages were calculated equally to the amount CNT-PLGA-CP3 groups. 
In general, certain amount of caspase-3 was dissolved PBS. Dry Pro-Ject film was 
hydrated and dispersed well by caspase-3 containing PBS solution. The mixed solution 
was incubated at room temperature for 5 mins and ready to be used. According the BD 
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protocol provided. An incubation time of 3-4 hours in serum free medium was required 
for protein transfection. 96 well plate was used for Pro-Ject transfection control. 20, 000 
cell/cm2 cell seeding density was used. 
 
4.2.4. Cell culture 
Osteosarcoma cells MG-63 (ATCC) were cultured in 90% α-MEM (Lonza) and 
10% FBS (Gibco) supplemented with 2 mmol/ml l-glutamine (Sigma). A serum free 
medium mentioned above was prepared without serum using the same recipe. Cells were 
placed in well plate with a seeding density of 20,000/cm2. Testing conjugates were 
introduced after 4 hours. This time point was set as 0 and cells were then maintained in a 
humidified incubator at 37°C with 5% CO2.  
 
4.2.5. MTT assay 
Cell viability was assessed using 3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) (Alpha Aesear) calorimetric assay at predetermined 
time points of 1, 3, 5 and 7 days. In brief, MTT/PBS solution was added into each well 
(1:5) and incubated at 37 °C for 5 h. This was followed by the removal of medium/MTT 
solution and addition of 1 ml dimethyl sulfoxide (DMSO) (Fisher). The resulting solution 
was diluted by DMSO in a ratio of 4:1 and the absorbance was read at 550 nm using 
Tecan SpectroFluo Plus reader. Cell viability was determined as the equation:  
550nm
550nm
Abs  of Treated Sample
Cell Viability= 100%






4.2.6. Spectra measurement 
XRD patterns were carried out on a Rigaku MiniFlex II with a scanning speed of 
0.2 degree/minute. UV was measured on a Jasco UV 60 UV-Vis spectrometer from 250 
to 500 nm. Fourier Transform Infra-Red (FTIR) spectrum was measured on a Nicolet 
6700 FT-IR spectrometer from 3600 to 400 cm-1.  
 
4.2.7. Immunofluorescent images 
To remain sterile, cover slips were rinsed in 70% ethanol for 10 minutes and 
washed with PBS. Cells were seeded onto cover slips and allowed 12 hours to expand on 
glass slides. The addition of 0.05, 0.1, 0.5, 1 and 3 µg/ml CNT-PLGA-fBSA conjugate 
was added and incubated for 4 hours. Then samples were washed with PBS, fixed with 
formalin (Sigma), and dried. Fluorescent images were taken with a Nikon Eclipse 60i 
microscope system and all images were analyzed with Nikon Elements NX4 software. 
 
4.2.8. TEM  
Cells were seeded onto 40 mesh carbon grids for 12 hours with a density of 
20,000 cells/cm2 followed by an addition of 3 µg/ml CNT-PLGA-BSA conjugate 
solution and incubated for 4 hours. Samples were then washed with PBS, fixed with 
formalin, and dehydrated by a series of ethanol treatments [164]. TEM images of the cell 






4.2.9. Temporal release profile of BSA from CNT-PLGA-BSA in vitro 
CNT-PLGA (100 µg) was dispersed in 0.5 ml of 2-(N-Morpholino)ethanosulfonic 
acid (pH 5.6) (MES) (Acros) buffer under sonication for 1 hour at room temperature. 
0.25 ml of 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (0.2 mol/l) 
(EDC) (Acros) and 0.25 ml N-Hydroxysuccinimide (0.1 mol/l) (NHS) (Acros) in MES 
solution were added to the activated carboxylate groups [170, 171]. The mixture was 
washed with PBS and centrifuged in a 100 kDa molecular weight cutoff centrifugal filter 
(Millipore) to remove EDC and NHS at 5,000 g three times for 30 minutes. Then, 200 µg 
of BSA was added to the CNT-PLGA/PBS solution at 4 oC overnight. Lastly, the mixture 
was washed and centrifuged in a cutoff filter to remove un-conjugated BSA six times at 
5,000 g for 30 minutes [171]. The removed filtered solution was collected each run to 
determine amount of loaded BSA. 
The CNT-PLGA-BSA conjugates were then dispersed in 1 mL PBS by sonication 
(5 min) and incubated in a water bath (37 oC). The entire conjugate solution was 
centrifuged in a 100 kDa molecular weight cutoff centrifugal filter (Millipore) to remove 
the released BSA solution at each predetermined time point. The concentration of the 
released BSA was determined with a Jasco UV 60 UV-Vis spectrometer at 280 nm with a 
pre-made calibration curve.  
 
4.2.10. Release of resveratrol from nanoparticles made of different PLGA in vitro 
In general, 100 mg of PLGA (Lactel) in differing ratios of PLA to PGA and 
molecular weight (5,000-16,000/50:50, 16,000-29,000/50:50 and 75,000-100,000/75:25) 
along with 10 mg of resveratrol (Sigma) were dissolved in 5 mL acetone (Sigma). The 
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mixture was then slowly injected into 100 mL 0.25 mol/ml MES solution (pH 5.0) 
containing 2.5% PVA (Sigma) at a rate of 1 mL/min [170, 171]. After 24 hours of 
moderate stirring to remove traces of acetone, the nanoparticle solution was centrifuged 6 
times to remove the non-incorporated resveratrol. The supernatants were collected to 
determine the loaded resveratrol. The collected nanoparticles were lyophilized and stored 
in a desiccator. 
The nanoparticles (1mg) were dispersed in 1 mL PBS by sonication (5min) in an 
EP tube and incubated in a water bath (37 oC). The nanoparticle suspension was 
centrifuged to collect the supernatant at each predetermined time point. The concentration 
of released resveratrol was determined with a Jasco UV 60 UV-Vis spectrometer at 327 
nm with a pre-made calibration curve (Supplementary Figure 3).  
 
4.2.11. Statistical analysis 
Five samples were analyzed at each condition. Data in graphs represents the mean 
± standard deviation (SD). Comparison between the two means was determined using the 
Tukey test and statistical significance was defined as p ≤ 0.05. 
 
4.3.      Result and discussion 
4.3.1. PLGA functionalization 
CNTs have been used previously to deliver biological materials across the cell 
membrane including proteins, DNA, and RNA. Developing the proper surface 
functionalization for CNTs is the most critical step for a desired application. The two 
major types of functionalization for CNTs are non-covalent and covalent bonds [52]. 
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Non-covalent binding is based on π-π stacking between the CNTs and aromatic groups 
from the linkers [180]. Liu et al. showed previously that DNA could be immobilized on 
pyrene derivatives of functionalized CNTs [270]. Other than these pyrene derivatives, 
single stranded DNA can also be used to immobilize CNTs [271], however DNA can be 
cleaved by serum, suggesting non-covalent reactions may not be stable in some cases 
[181]. For covalent binding, reactive groups are usually formed by various oxidation 
methods [175, 176] which allow for further modifications to enhance polymer [177], 
protein [178] and DNA [132] attachment. Functionalized CNTs can also be easily 
dispersed in water, which allows for forming supermolecular bioconjugates such as 
PLGA and PEG. PLGA is a FDA approved polymer for clinic use with the unique ability 
to control degradation rate, which allows us to tune the drug release profile. PEG is 
another commercially manufactured clinic material which has been used to conjugate 
with CNTs to deliver siRNA by the instant cleavage of S-S bond.  PEG has only one type 
of functional group and smaller average molecular weight compared to PLGA. Further 
modifications are required to attach active biological cargoes to PEG and control its 
release profile. To this end, a novel CNT-PLGA based drug delivery system has several 
advantages including a high transfection rate, reduced toxicity, and a highly controlled 







Figure 4. 1 Schematic of drug delivery into cells, carbon nanotubes is oxidized to form 
new carboxyl groups, linked with PLGA and functionalized by caspase-3. The 
conjugates penetrated into MG-63 cells and release caspase-3 by degradation of 
PLGA. 
 
In this study, a novel CNT based drug delivery system as depicted in Figure 4. 1 
was developed. In general, pristine CNTs as shown in Figure 4. 2 were oxidized in nitric 
acid to form carboxyl groups. Carboxyl groups of CNTs were then activated by oxalyl 
chloride forming CNT-acyl chloride and attached to the PLGA [177]. PLGA is able to 
provide attachment for the desired transcription factor CP3 by replacing chloride. The 
CNT-PLGA-CP3 conjugate can be easily dispersed in PBS without aggregation, which 
otherwise would hinder penetration of the cell membrane. Due to the enzymatic 
degradation of PLGA, CP3 would is able to be released gradually and induce cell 
apoptosis. The CNT-PLGA-CP3 conjugations are stable for weeks at -20 oC and the 




Figure 4. 2 TEM image of carbon nanotubes. The result showed 
that pristine carbon nanotubes has no outside coating. Our CNTs 
are about 5 µm in length with a diameter about 20 µm. 
 
XRD, UV, IR and TEM were used to investigate the CNT-PLGA complex. In 
Figure 4. 3A, all XRD patterns were roughly the same in the region larger than 35 
degrees which represents the crystal structure of the C-H bond, sp2 hybrid C-C bond, and 
C-O bond [3]. However, PLGA patterns showed a peak, which denoted the amorphous 
region of PLGA polymers from 10-25 degree as shown in Figure 4. 3B. This peak can be 
determined as a characteristic of PLGA, which CNTs alone do not possess. A small peak 
at 22.7 degree for amorphous PLGA and a peak at 24.1 degree for CNTs were observed, 
indicating PLGA attachment to CNTs. However, this peak was not as pronounced as 
observed in pattern A. We believe only small amounts of PLGA were able to bind to 




Figure 4. 3 Characterization of CNT-PLGA complex. A is XRD pattern, B is XRD 
pattern as well. C is UV-Vis spectrum, D is TEM image. Results showed that 
PLGA is successfully attached to carbon nanotubes. A small peak at 22.7 degree for 
amorphous PLGA and a peak at 24.1 degree for CNTs found in XRD pattern were 
indicating PLGA attachment to CNTs. UV absorption at 260 nm of CNT-PLGA 
indicated PLGA and CNTs were present. Dark PLGA layer clearly shown coated 
over the CNTs with a depth of several nanometers by TEM. 
 
CNTs have a simple flat UV absorption and start to decrease from 280 nm as 
shown in Figure 4. 3C. PLGA didn’t show a similar trend instead showing a strong 
absorption at 260 nm similar to Cheng’s finding [272]. CNT-PLGA showed absorption at 
260 nm indicating PLGA and a flat decreasing trend thereafter, indicating CNTs were 
present. This finding showed a similar trend to CNT-Paclitaxel [133]. Through FTIR 
spectra CNTs showed a typical sp2 hybrid C-C stretching at 1200 cm-1, while no O-H 
stretching was observed at 3400 cm-1 as shown in A. On the contrary, O-H stretching and 
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C=O stretching at 1650 cm-1 were observed in CNT-PLGA. This denoted a successful 
attachment of PLGA to the CNTs. In addition to FTIR, TEM was used to observe the 
PLGA linkage to CNTs. Pristine multi-wall CNTs in Figure 4. 2 with no PLGA 
functionalization was compared to the dark PLGA layer clearly shown coated over the 
CNTs with a depth of several nanometers in Figure 4. 3D. 
 
4.3.2. Protein attachment 
 
Figure 4. 4 Characterization of protein conjugation. A is Infra-red spectrum, B 
is light microscopy of CNT-PLGA-BSA, C is fluorescent images of CNT-
PLGA-fBSA. Results showed that proteins has been successfully attached to 
CNT-PLGA complex, forming CNT-PLGA-BSA conjugates. CNT-PLGA-
BSA showed a peak around 1400 cm-1 indicating amide III belt in IR, which is 
the typical peak of BSA. A single CNT-PLGA attached to fBSA was observed 
through immunofluorescence indicating successful conjugation. 
 
DNA and RNA are the genetic material generally transported by functionalized 
CNTs. In 2004, Pantarotto discovered CNTs as a tool to transport DNA plasmids [128]. 
Further research found DNA was protected by CNTs during cellular uptake [273]. In 
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addition, Zhang et al. successfully transported telomerase inhibited small interference 
RNA into tumor cells and suppressed their growth [274]. However, researchers generally 
used protein fictionalization for stabilizing [275], labeling [276] and separating [277] 
CNTs rather than transporting functional protein to tune cellular behavior. Here, we were 
able to conjugate protein to CNT-PLGA complex. 
 Protein typically has a UV absorption at 280 nm due to sp2 hybrid C-C in Phe, 
Tyr, and Trp which is a similar structure to CNTs. Protein also has a similar amorphous 
region in XRD pattern as most polymers. Therefore, XRD and UV are not appropriate 
methods to confirm protein attachment so we used FTIR and fluorescently tagged BSA to 
confirm the attachment of protein. As shown in Figure 4. 4A, CNT-PLGA-BSA showed a 
peak around 1400 cm-1 indicating amide III belt, which is the typical peak of BSA. fBSA 
was then used to attach to CNT-PLGA and in Figure 4. 4B and Figure 4. 4C, a single 
CNT-PLGA attached to fBSA was observed through immunofluorescence indicating 
successful conjugation. CNTs are generally auto fluorescent over 800 nm [278] but no 
fluorescent signal was observed at those wavelengths confirming the protein attachment. 
 
4.3.3. Cellular transfection by CNT-PLGA-fBSA conjugates  
The ideal vector to deliver biological material should have two basic 
characteristics being high efficiency and safety. In terms of efficiency, we investigated 
the cellular uptake ability of CNT-PLGA-fBSA and CNTs were found to have the ability 
to penetrate cells due to their nano-sized diameter and small radius to volume ratio [279]. 
In demonstrating the high efficiency to penetrate cells, we tested the transfection ability 





Figure 4. 5 Optic and fluorescent combined images of CNT-PLGA-fBSA delivery into 
MG-63 osteosarcoma cells. All images are 20 X. The dosage culture with osteosarcoma 
cells are 0.05 g×ml-1, 0.1 g×ml-1, 0.5 g×ml-1, 1 g×ml-1 and 3 g×ml-1, respectively. 
The results showed that CNT-PLGA-fBSA can easily penetrate into cells and transduce 
osteosarcoma cells. The CNT-PLGA-fBSA conjugates showed a pronounced ability to 
penetrate cells with a transfection rate close to 100% at all conducted concentrations, 




In order to prevent non-specific background signals, cells were carefully washed 
to remove any non-penetrated CNT-PLGA-fBSA conjugates. We were able to observe 
fluorescent signals in cells as shown in Figure 4. 5. The CNT-PLGA-fBSA conjugates 
showed a pronounced ability to penetrate cells with a transfection rate close to 100% at 
all conducted concentrations, ranging from 0.05 to 3 g/ml.  
 
Figure 4. 6 Determination of carbon nanotubes delivered into osteosarcoma cells. 
The dosage 3 g×ml-1. A is osteosarcoma cells cultured with CNT-PLGA-fBSA. B 
is image of fluorescent signal within osteosarcoma cells. C is the optic and 
fluorescent combined image of CNT-PLGA-fBSA image. D is the TEM image of a 
single CNT-PLGA-BSA penetrating the cell body. The results showed that the 
conjugates penetrate the cells.  
 
The high magnification images of Figure 4. 6A, Figure 4. 6B, and Figure 4. 6C 
were able to show higher resolutions around the nuclei which showed higher fluorescent 
signal, coinciding where large amounts of ribosomes reside. This location of the CNT-
PLGA-fBSA conjugate facilitates RNA and transcription factor delivery. TEM was also 
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used to confirm cell penetration as shown in Figure 4. 6D, where clearly there is a CNT-
PLGA-BSA conjugate penetrating into the cytosol, demonstrating the ability of CNTs to 
transport material across the membrane. We have successfully achieved a transfection 
rate higher than the 30% or 40% attained by polymers and liposome nanoparticles 
indicating the promise in non-viral gene delivery vectors. 
 
4.3.4. The efficacy of CNT-PLGA-CP3 in tuning apoptosis 
 Commonly used drugs for cancer therapies are alkalating agents, anti-metabolites, 
plant alkaloid and terpenoids, topoisomerase inhibitors, and cytotoxic antibiotics.  These 
chemicals usually have side effects which not only kill cancer cells, but also induce 
necrosis of normal tissue. In order to prevent the side effects, we chose caspase-3 (CP3) 
as a potential candidate. CP3 is the key enzyme that is highly involved in the cell 
apoptosis pathway. Apoptosis is an organized process that signals cells to self-destruct 
for cell renewal or to control aberrant cell growth. Apoptosis controls the orderly death of 
damaged cells, whereas necrosis occurs as a result of tissue damage, causing the loss of 
both damaged and surrounding cells [280]. There are two routes for apoptosis pathway: 
intrinsic and extrinsic.  
Intrinsic apoptotic stimuli, such as DNA damage or endoplasmic reticulum (ER) 
stress, activate B cell lymphoma 2 (BCL-2), homology 3 (BH3)-only proteins. This 
activation leads activate BCL-2-associated X protein (BAX) and BCL-2 antagonist or 
killer (BAK) and mitochondrial outer membrane permeabilization (MOMP). Following 
MOMP, release of various proteins from the mitochondrial intermembrane space 
promotes caspase activation and apoptosis. Cytochrome c binds apoptotic protease-
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activating factor 1 (APAF1), inducing its oligomerization and thereby forming a structure 
termed the apoptosome that recruits and activates an initiator caspase: caspase-9. 
Caspase-9 cleaves and activates executioner caspases: caspase-3 and caspase-7, leading 
cells to apoptosis [281].  
The extrinsic apoptotic pathway is initiated by the ligation of death receptors with 
their cognate ligands, leading to the recruitment of adaptor molecules such as FAS-
associated death domain protein (FADD) and then caspase-8. This results in the 
dimerization and activation of caspase-8, which can then directly cleave and activate 
caspase-3 and caspase-7, leading to apoptosis [281]. What’s interesting here is that 
caspase-3 is the downstream and key enzyme responsible in leading cells to apoptosis for 
both routes. Thus we chose caspase-3 for our study in cancer therapy. 
We used MTT assays to test the cell viability as a standard to measure the ability 
of CNT-PLGA-CP3 to release CP3. The working concentration is set very low in order to 
eliminate cell necrosis induced by large amount of CNTs. Researchers has demonstrated 
that functionalized CNTs were found to be less toxic than pristine CNTs [282, 283] and 
pristine CNTs in low concentrations are also able to exhibit acceptable toxicity levels 
[284]. So cell death experienced in this experiment is attributed to the contribution of 
CP3 delivered into cells inducing apoptosis.  
Pro-Ject is commercially available liposomes for protein delivery; we use Pro-Ject 
liposomes as a positive control in comparison to our CNT-PLGA-CP3 conjugation. As 
shown in Figure 4. 7A, no significant differences were observed in CNT-PLGA-CP3 
groups on day 1, however, Pro-Ject groups showed significant difference in comparison. 
We attribute this to the fact that the degradation of PLGA hasn’t fully allowed the release 
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of significant amounts of CP3 [285]. Pro-Ject liposomes released material with minimal 
differences in dosage on Day 1. We hypothesize that the average amount of CP3 
delivered was significant enough to induce apoptosis even at minimal concentrations.  
 
Figure 4. 7 Cell viability on day 1 (A) and day 3 (B) of MG-63 cells under 
exposure of different dosages of carbon nanoutbes, CNT-PLGA, CNT-PLGA-
BSA, caspase-3, Pro-Ject and CNT-PLGA-CP3 treatment. * means significant 
difference of cell viability under CNT-PLGA-CP3 cojugates exposure and other 
groupes of same dosage. Results showed that carbon nanotubes have a great 
ability to penetrate cells and release caspase-3. Our conjugation can release 
caspase-3 in a week. 
 
Interestingly, the cell viability of all Pro-Ject liposome samples average at 
approximately 50%.  Considering the CP3 was enough to induce apoptosis, the efficiency 
of Pro-Ject liposome groups was close to 50%. Figure 4. 7B shows the cell viability of 
 
96 
CNT-PLGA-CP3 treated samples were significantly small compared to positive and 
negative controls on Day 3. Pro-Ject liposome groups treated samples showed minimal 
differences in this case, indicating there was little to no consistency of material delivery 
over long periods. Conjugate dosage played an important role in inducing cell apoptosis 
with no significant differences observed between CNT-PLGA-CP3 in low dosages and 
controls while CNT-PLGA-CP3 conjugates in high concentration exhibited a 
significantly low cell viability compared to other controls. We believe the amount of 
transcription factor reacting with the CNT-PLGA complex is same but the amount of 
CP3 released was highly dependent on the conjugate dosage.  
We also conducted long-term cell viability tests at two high dosages with no 
additional treatments throughout the experiment. The results shown in Figure 4. 7C and 
Figure 4. 7D show that cell viability was still suppressed by treating 1 µg/ml CNT-
PLGA-CP3 on Day 5 and 3 µg/ml CNT-PLGA-CP3 on Day 7, respectively. Note that 
cancer cells were able to recover and become fully confluent under Pro-Ject liposome 
groups between Day 1 and Day 3. We believe CP3 is superior due to the gradual release 
profile. To further demonstrate this point in vitro, we carried out BSA release profile in 
vitro. 
In order to detect the BSA release with a UV-Vis spectrometer, we increased the 
amount of BSA (200 µg compared to 5 µg of caspase-3) reacting with the CNT-PLGA 
complex. This increased amount of BSA resulted in BSA released at detectable levels 
through UV-Vis spectrometer. A calibration curve was made to calculate the protein 
concentration (Figure 4. 8). The protein loaded onto 100 µg of CNT-PLGA was 
119±6.73 µg per 200 µg. We observed a gradual release of BSA through the time points 
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in the 10-day trial (). Throughout the first two days we saw only a slight release of BSA 
while more than 5 µg of BSA was released after Day 7. This is a possible explanation for 
the CNT-PLGA-CP3 conjugates showing limited inhibitory effects on Day 1 while the 
CNT-PLGA-CP3 conjugates showed significantly higher inhibitory effects after Day 3.  
With only 5 µg of CP3 in the starting reaction, this may help explain the inhibitory 
effects on cell growth diminishing after Day 7. We also observed an increase in BSA 
released from Day 8 to Day 10. This is because the large molecular weight PLGA was 
hydrolyzed to a small fraction, which leads to an increase in protein release. Due to the 
fact that the CNT-PLGA-CP3 conjugates face a more complicated enzymatic 
environment, it is extremely difficult to quantitatively monitor the release profile in situ. 
However, this release profile data in combination with our cytotoxicity data give us 
confidence in the reliability of our results. 
 
Figure 4. 8 Calibration curve of  BSA concentration vs UV 
aborption at 280 nm. 
 
 






























Figure 4. 9. BSA release fraction from the CNT-PLGA-
BSA conjugates at predetermined time points. CNT-




4.4.      Conclusions 
We were able to successfully fabricate a CNT-PLGA system, which is able to 
deliver biological material including genes, transcriptional factors, and signal molecules 
into cells. This system has shown a high transfection rate and a reliable, time dependent 
release profile. Yet another advantage to this system is that the releasing profile can be 
tuned simply by controlling the molecular weight and ratio of PLGA.  
In determining the release profiles of the CNT-PLGA with differing PLGA to 
PGA and molecular weights, we simplified the experiment using PLGA nanoparticles as 
an alternative. A calibration curve was made (Figure 4. 10). We observed in general that 
resveratrol was gradually released from all three groups of PLGA nanoparticles (Figure 
4. 11). Note that because the resveratrol was not covalently bound to the PLGA, the 

























release fraction of resveratrol is higher than that of BSA, which is covalently bound to the 
CNT-PLGA complex. The amount of resveratrol loaded on to the PLGA nanoparticles 
are 38%, 36%, and 40%. Interestingly, the 3 groups of PLGA nanoparticles showed 
different trends of release profiles with the smaller molecular weight PLGA nanoparticles 
releasing more resveratrol than the higher molecular weight counterparts. Considering the 
method to covalently bind the protein to the CNT-PLGA, the conjugates would require 




Figure 4. 10. Calibration curve of resveratrol concentration 
versus UV absorption at 327 nm.  
 
































Figure 4. 11 Resveratrol release fraction from the PLGA 
nanoparticles. PLGA nanoparticles were made from 
PLGA with differing ratios of PLA to PGA and 
molecular weight (5,000-16,000/50:50, 16,000-
29,000/50:50 and 75,000-100,000/75:25). Resveratrol 
was released more at the same time point by 
nanoparticles made by low molecular weight PLGA. 
 
In all aspects, this CNT-PLGA-protein conjugation is a highly efficient and 
promising as drug delivery system with possible future applications in both treating 
cancer and directing cellular behavior through intracellular pathways. More attractively, 
despite the self-fluorescence of CNTs, fluoresce proteins can be conjugated to CNTs for 
the purpose of imaging hazard distribution, drug bio distribution and disease detection.  
The most innovative aspect of our conjugates is that our DDS system based on 
CNT-PLGA is that we can tune the temporal release profile by controlling the molecular 
weight and PGA to PLA ratio, which so far has not been established yet. By employing 
this DDS system, we can incorporate a cocktail of the drugs either for cancer treatment or 







































stem differentiation, and deliver this cocktail of drugs sequentially by just one shot. This 








CNTs for biomedical engineering has been an emerging area. CNTs are promising 
candidate in tissue engineering, biomedical imaging and gene delivery. In the previous 
three chapters, we demonstrated the ability of CNTs as extracellular and intracellular cues 
to control cellular behaviors.  
As extracellular matrix, we developed an aligned CNT substrate to align HUVEC 
and culture hESCs at single cell level (Chapter2). We functionalized carboxyl CNTs with 
the ligand proteins and aligned these CNT-ligand conjugates on an Au coated glass 
substrate by spin coating. With this our newly developed CNT substrate, we can culture 
hESCs at single cell level, and can control their migrating as demonstrated by HUVEC. 
This was the great novelty in the Chapter 2. By culturing single hESC, we can take a step 
forward to different single hESCs to desired phenotype with limited heterogeneity. This 
would allow us for better understanding differentiation of hESC at single cell level.  
We also developed a CNT containing PLGA scaffolds for bone regeneration in 
Chapter 3. Mechanically strengthened CNT/PLGA scaffolds were fabricated through a 
dispersion of CNT in PLGA/dichloromethane solution followed by a solvent casting and 
particulate leaching step. The incorporation of CNTs allowed for tuning the mechanical 
strength and nano roughness without compromising the porous architecture of scaffolds. 
 
103 
Our results demonstrated that the addition of CNT to PLGA scaffolds led to a 
significant increase in adhesion, growth and osteogenic differentiation of cells. We were 
able to confirm the coupling of matrix stiffness and mechanical strength to enhanced 
osteogenesis in 3D environment by those results. Note that previous reports have just 
related only one of these two aspects to osteogenesis. Our results first demonstrated 
mechanical strength and nano roughness were link to osteogenesis together. This finding 
demonstrated CNTs to be a powerful tool in scaffolds design for stem cell based tissue 
engineering.  
As intracellular cue vesicles, a number of biological cargo has been already 
delivered intracellularly by a several types of linkers such as PEG or not. We developed a 
new CNT-PLGA conjugate to delivery biological cargoes into cells in Chapter 5. This 
system waas able to deliver biological material including genes, transcriptional factors, 
and signal molecules into cells with a high efficiency. The most innovative aspect of our 
conjugates was that our DDS system based on CNT-PLGA can tune the temporal release 
profile by controlling the molecular weight and PGA to PLA ratio, which so far has not 
been established yet. By employing this DDS system, we can incorporate a cocktail of the 
drugs either for cancer treatment or stem differentiation, and deliver this cocktail of drugs 
sequentially by just one shot. This invention would help patients relieved at significant 
level. More attractively, despite the self-fluorescence of CNTs, fluoresce proteins can be 
conjugated to CNTs for the purpose of imaging the hazard distribution, drug bio 
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